Upload
dodung
View
225
Download
0
Embed Size (px)
Citation preview
1 /
Sede Amministrativa: Università degli Studi di Padova
Dipartimento di Biologia
SCUOLA DI DOTTORATO DI RICERCA IN BIOSCIENZE E BIOTECNOLOGIE
INDIRIZZO BIOLOGIA CELLULARE
CICLO XXV
A Novel Ca2+
Release Channel in Mitochondria
of Drosophila melanogaster: Properties and
Role in Ca2+
Homeostasis
Direttore della Scuola: Ch.mo Prof. Giuseppe Zanotti
Coordinatore d’indirizzo: Ch.mo Prof. Paolo Bernardi
Supervisore: Ch.mo Prof. Paolo Bernardi
Dottorando: Sophia von Stockum
31 DICEMBRE 2012
2
3 /
“We must not forget that when radium was discovered no one knew that it
would prove useful in hospitals. The work was one of pure science. And this
is a proof that scientific work must not be considered from the point of
view of the direct usefulness of it. It must be done for itself, for the beauty
of science, and then there is always the chance that a scientific discovery
may become like the radium a benefit for humanity. ”
- Marie Curie, Lecture at Vassar College, 1921-
The scientist is not a person who gives the right answers, he's one who asks
the right questions.
-Claude Lévi-Strauss, Le Cru et le cuit, 1964-
dedicated to my parents
4
5 /
TABLE OF CONTENTS
SUMMARY ......................................................................................................... 1
SOMMARIO........................................................................................................ 5
LIST OF PUBLICATIONS ..................................................................................... 9
LIST OF ABBREVIATIONS ................................................................................. 11
INTRODUCTION ............................................................................................... 13
1 Mitochondria .......................................................................................................15
1.1 Mitochondrial morphology ................................................................................15
1.2 Mitochondrial energy production ...................................................................... 17
1.3 Mitochondrial control of apoptosis ................................................................... 20
2 Cellular Ca2+ homeostasis ................................................................................... 24
2.1 The role of mitochondria .................................................................................. 25
2.2 Mitochondrial Ca2+ influx and efflux mechanisms ............................................ 26
2.3 The problem of Ca2+ overload: a constant threat for mitochondria .................. 27
3 The permeability transition pore (PTP) .............................................................. 28
3.1 Features and regulation of the PTP in mammals ............................................. 29
3.2 Structure .......................................................................................................... 32
3.3 The PTP as a Ca2+ release channel .................................................................... 34
3.4 The PTP in other species: a channel conserved through evolution? ................. 36
3.5 Ca2+ transport and PT in yeast mitochondria ................................................... 36
4 Cyclophilins ........................................................................................................ 38
4.1 Cyclophilin D .................................................................................................... 38
5 The fruit fly Drosophila melanogaster ................................................................. 40
5.1 Drosophila as a model organism ....................................................................... 41
5.2 Drosophila cell lines .......................................................................................... 42
5.3 Drosophila mitochondria in research ................................................................ 43
5.4 Involvement of Drosophila mitochondria in apoptosis ...................................... 45
MATERIALS AND METHODS ............................................................................. 49
I. S2R+-cells .............................................................................................................51
I.1 Cell culture .........................................................................................................51
6
I.2 Cell permeabilization ........................................................................................ 51
I.3 Subcellular fractionation .................................................................................. 51
I.4 Stable Transfection ...........................................................................................52
II. Mitochondrial bioenergetics ...............................................................................52
II.1 Measurement of mitochondrial respiration ......................................................52
II.2 Measurement of mitochondrial membrane potential ...................................... 53
III. Mitochondrial Ca2+ transport and permeability transition .................................. 54
III.1 Measurement of mitochondrial Ca2+ fluxes and Ca2+ retention capacity ......... 54
III.2 Light scattering ............................................................................................... 56
IV. Epifluorescence microscopy ............................................................................... 56
IV.1 Fluorescent staining of S2R+ cell mitochondria ............................................... 56
IV.2 Immunofluorescence ....................................................................................... 57
V. Electron microscopy ...........................................................................................58
VI. SDS-PAGE and Western Blotting ........................................................................58
VI.1 Sample preparation .........................................................................................58
VI.2 SDS-PAGE .......................................................................................................58
VI.3 Western Blotting ............................................................................................. 59
VII. Plasmids and constructs ..................................................................................... 60
VII.1 Cloning of human Cyp-D cDNA into a Drosophila expression vector ............. 60
RESULTS ......................................................................................................... 65
Part I: Properties of a Selective Ca2+-induced Ca2+ Release Channel in Mitochondria of
Drosophila melanogaster ............................................................................................ 67
Publication 1 .............................................................................................. 68
Part II: Expression of Human Cyclophilin D in Drosophila melanogaster Cells – Impact
on Regulation of the Drosophila Mitochondrial Ca2+ Release Channel ........................ 78
CONCLUSIONS................................................................................................. 83
REFERENCES ................................................................................................... 87
APPENDIX ..................................................................................................... 105
A. Publication 2 .................................................................................................... 107
B. Publication 3 .................................................................................................... 113
7 /
LIST OF FIGURES
Figure 1. Mitochondrial morphology in fibroblasts and cardiomyocytes. ...................................15
Figure 2. Cryotomogram from isolated rat liver mitochondrion. ............................................... 16
Figure 3. Schematic representation of the mitochondrial respiratory chain, composed of four
multimeric complexes, and of the ATP synthase (complex V).. ................................................. 20
Figure 4. Intrinsic and extrinsic pathway of apoptosis. .............................................................. 23
Figure 5. Schematic representation of the Ca2+ homeostatic network between endoplasmatic
reticulum, mitochondria and cytosol. ....................................................................................... 25
Figure 6. Schematic representation of mitochondrial Ca2+ uptake and efflux mechanisms ....... 27
Figure 7. Mechanisms of mitochondrial permeabilization and release of intermembrane space
proteins due to the opening of the permeability transition pore. .............................................. 29
Figure 8. Modulation of the permeability transition pore by Cyclophilin D and Phosphate in
mammalian mitochondria. ........................................................................................................ 31
Figure 9. Modulators of the permeability transition pore in mammals ...................................... 32
Figure 10. Life cycle of Drosophila melanogaster. ...................................................................... 40
Figure 11. Schematic representation of key proteins in mitochondrial-induced apoptotic
pathways in vertebrates and their Drosophila homologues. ...................................................... 46
Figure 12. Interaction of the key players in Drosophila cell death. ............................................. 47
Figure 13. Schematic representation of a polarographic Clark type oxygen electrode trace.. .... 53
Figure 14. Evaluation of mitochondrial membrane potential (ΔΨm) based on Rhodamine123
fluorescence.. ........................................................................................................................... 54
Figure 15. Calcium Retention Capacity (CRC) assay. ................................................................. 55
Figure 16. Schematic representation of the light scattering technique as indicator of
mitochondrial volume changes.. ............................................................................................... 56
Figure 17. cDNA sequence of the MTS-CypD-HA construct. ..................................................... 61
Figure 18. pGEM®-T vector map and sequence reference points. ............................................. 62
Figure 19. pAct vector map. ...................................................................................................... 63
Figure 20. pCoPuro vector map and sequence reference points. ............................................... 64
Figure 21. Expression level and subcellular localization of human Cyclophilin D expressed in
Drosophila S2R+ cells.. ............................................................................................................... 80
Figure 22. Effect of human Cyp-D on mitochondrial Ca2+ retention capacity (CRC) in
permeabilized Drosophila S2R+ cells.. ........................................................................................ 82
LIST OF TABLES
Table 1. List of all primary antibodies for Western Blotting used in this work. ............................ 59
Table 2. Primers used for generation of a cDNA MTS-CypD-HA construct. ................................... 60
Table 3. PCR amplification protocol for generation of a cDNA MTS-CypD-HA construct. .......... 61
Table 4. Colony PCR amplification protocol for detection of MTS-CypD-HA-positive clones. ....... 62
8
1
SUMMARY
SUMMARY
2
3
Mitochondrial Ca2+ uptake and release play a pivotal role in different physiological
processes such as intracellular Ca2+ signaling and cell metabolism, while their
dysregulation can lead to cell death induction. In energized mitochondria the Ca2+
uniporter (MCU) mediates Ca2+ uptake across the inner mitochondrial membrane (IMM)
while the Na+/Ca2+ exchanger and the H+/Ca2+ exchanger are responsible for Ca2+ efflux.
However, when mitochondrial matrix Ca2+ load exceeds the capacity of the efflux
pathway by exchangers, an additional pathway for Ca2+ release from mitochondria may
exist through opening of the permeability transition pore (PTP). The mitochondrial
permeability transition (PT) describes a process of Ca2+-dependent, tightly regulated
increase in the permeability of the IMM to solutes with molecular masses below 1500
Da, due to the opening of a high-conductance channel, the PTP. Prolonged PTP
opening causes several effects, such as depolarization, osmotic swelling, outer
mitochondrial membrane rupture and release of apoptogenic proteins like cytochrome
c (cyt c). Transient openings of the PTP on the other hand, might be involved in
physiological Ca2+ homeostasis and may protect mitochondria from Ca2+ overload.
Several studies allowed a thorough characterization of the functional properties and
regulation of the putative channel, but its molecular nature remains still elusive. One of
the best defined modulators of the PTP is the mitochondrial peptidyl-prolyl-cis-trans-
isomerase (PPIase) Cyclophilin D (Cyp-D), that plays an important role in protein folding
and can be selectively inhibited by the immunosuppressant drug Cyclosporin A (CsA).
In spite of its importance as a model organism and as a genetic tool, remarkably little is
known about the properties of Ca2+ transport in mitochondria of the fruit fly Drosophila
melanogaster, and on whether these mitochondria can undergo a PT. In this study we
have characterized the pathways of Ca2+ transport in the digitonin-permeabilized
embryonic Drosophila cell line S2R+. We demonstrated the presence of ruthenium red-
sensitive Ca2+ uptake, and of Na+-stimulated Ca2+ release in energized mitochondria,
which match well characterized Ca2+ transport pathways of mammalian mitochondria.
Furthermore we identified and characterized a novel mitochondrial Ca2+-dependent
Ca2+ release channel in Drosophila. Like the mammalian PTP, Drosophila Ca2+ release is
inhibited by tetracaine and opens in response to matrix Ca2+ loading, IMM
depolarization and thiol oxidation. As the yeast pore (and at variance from the
SUMMARY
4
mammalian PTP), the Drosophila channel is inhibited by Pi and insensitive to CsA. A
striking difference between the pore of Drosophila and that of mammals is its selectivity
to Ca2+ and H+ and the lack of mitochondrial swelling and cyt c release during the
opening of the channel.
The apparent absence of a mitochondrial Cyp in Drosophila prevents an investigation
based on the effects of CsA, a classical inhibitor of the mammalian PTP. Thus, in the
second part of this study we expressed human Cyp-D in Drosophila S2R+ cells in order to
investigate its impact on the Ca2+-induced Ca2+ release channel. Preliminary Ca2+
retention capacity studies demonstrated that human Cyp-D induces opening of the
Drosophila Ca2+ release channel in a rotenone-sensitive but CsA-insensitive manner. If
the Cyp-D in Drosophila cells changes selectivity, size and properties of the Ca2+-
induced Ca2+ release channel can now be addressed.
We conclude that Drosophila mitochondria possess a selective Ca2+ release channel with
features intermediate between yeast and mammals that is probably involved in Ca2+
homeostasis but not in Ca2+-mediated cell death induction. In this study we paved the
way for the application from the sophisticated genetic strategies that Drosophila
provides to define the molecular nature of the PTP and its role in pathophysiology of
Ca2+ homeostasis.
5 SOMMARIO
SOMMARIO
6
7 SOMMARIO
L’accumulo e il rilascio di Ca2+ da parte dei mitocondri svolge un ruolo centrale in diversi
processi fisiologici, come nelle vie di segnalazione intracellulari e nel metabolismo
cellulare, mentre la loro disregolazione può indurre la morte cellulare. In mitocondri
energizzati, l’uniporto del Ca2+ (MCU) media l’accumulo di Ca2+ attraverso la membrane
mitocondriale interna (MMI) mentre gli scambiatori Na+/Ca2+ e H+/Ca2+ sono responsabili
del suo efflusso. Tuttavia, quando il carico di Ca2+ nella matrice mitocondriale supera la
capacità di efflusso attraverso gli scambiatori, potrebbe attivarsi una via aggiuntiva di
rilascio di Ca2+, attraverso l’apertura del poro di transizione di permeabilità (PTP). La
transizione di permeabilità (TP) consiste nell’aumento della permeabilità della MMI a
soluti con massa molecolare inferiore a 1500 Da, è un processo Ca2+-dipendente,
strettamente regolato, e dovuto all’apertura di un canale ad alta conduttanza, il PTP. La
prolungata apertura del PTP provoca diversi effetti, come la depolarizzazione, il
rigonfiamento osmotico, la rottura della membrana mitocondriale esterna e il rilascio di
proteine pro-apoptotiche come il citocromo c (cit c). L’apertura transiente del PTP,
invece potrebbe essere coinvolta nell’omeostasi fisiologica del Ca2+ e potrebbe
proteggere i mitocondri da un sovraccarico dello stesso. Diversi studi hanno consentito
una caratterizzazione accurata delle proprietà funzionali e della regolazione del canale
putativo, ma la sua natura molecolare rimane ignota. Uno dei miglior modulatori
caratterizzati del PTP è la peptidil-prolil-cis-trans-isomerasi mitocondriale Ciclofilina D
(Cip-D), che svolge un ruolo importante nel ripiegamento delle proteine e può essere
selettivamente inibita dal farmaco immunosoppressore Ciclosporina A (CsA).
Nonostante la sua importanza come organismo modello e come strumento genetico,
poco si conosce a proposito delle proprietà di trasporto di Ca2+ mitocondriale del
moscerino della frutta Drosophila melanogaster e dell’eventualità che i suoi mitocondri
possano subire una TP. In questo studio abbiamo caratterizzato le vie di trasporto di
Ca2+ mitocondriale nella linea cellulare embrionica di Drosophila S2R+, permeabilizzata
con la digitonina. Abbiamo dimostrato la presenza di un effettivo accumolo di Ca2+,
sensibile al rosso rutenio, come anche il rilascio di Ca2+ stimolato dal Na+ in mitocondri
energizzati, processi che corrispondono alle ben caratterizzate vie di trasporto di Ca2+ in
mammiferi. Inoltre, abbiamo identificato e caratterizzato un nuovo canale di rilascio del
Ca2+ indotto dal Ca2+ stesso in Drosophila. Come il PTP dei mammiferi, il canale di
8
rilascio di Ca2+ in Drosophila è inibito da tetracaina e apre in risposta al carico di Ca2+
nella matrice, depolarizzazione della MMI ed ossidazione di tioli. Come il poro in lievito
(e in contrasto con il PTP dei mammiferi), il poro di Drosophila è inibito da Pi e
insensibile alla CsA. Le principali differenze il poro di Drosophila e quello dei mammiferi
sono la sua selettività per Ca2+ e H+, e la mancanza di rigonfiamento mitocondriale e il
rilascio di cit c conseguente all’apertura del canale.
L’apparente assenza di una Cip mitocondriale in Drosophila impedisce uno studio basato
sugli effetti della CsA, un classico inibitore del PTP dei mammiferi. Perciò, nella seconda
parte di questo studio abbiamo espresso la Cip-D umana nelle cellule S2R+ di Drosophila
al fine di indagare il suo impatto sul canale di rilascio del Ca2+. Preliminari studi di
capacità di ritenzione del Ca2+ hanno dimostrato che la Cip-D umana induce l’apertura
del canale di rilascio del Ca2+ in Drosophila in modo rotenone-sensibile ma CsA-
insensibile. Se la Cip-D in Drosophila cambia la selettività, la grandezza e le proprietà del
canale di rilascio del Ca2+ può ora essere investigato.
Concludiamo che i mitocondri di Drosophila possiedono un canale selettivo di rilascio di
Ca2+ con caratteristiche intermedie tra il lievito e i mammiferi che probabilmente è
coinvolto nell’omeostasi del Ca2+, ma non nell’induzione della morte cellulare mediata
dal Ca2+. In questo studio abbiamo spianato la strada per l’applicazione delle strategie di
genetica sofisticate, che la Drosophila offre per definire la natura molecolare del PTP ed
il suo ruolo nella patofisiologia dell’omeostasi del Ca2+.
9 LIST OF PUBLICATIONS
LIST OF PUBLICATIONS
� Luca Azzolin, Sophia von Stockum, Emy Basso and Paolo Bernardi. The
mitochondrial permeability transition from yeast to mammals. FEBS Letters
(2010), vol. 584; p. 2504-2509
� Sophia von Stockum, Emy Basso, Valeria Petronilli, Patrizia Sabatelli, Michael A.
Forte and Paolo Bernardi. Properties of Ca2+ transport in mitochondria of
Drosophila melanogaster. The Journal of Biological Chemistry (2011), vol. 286; p.
41163-41170
� Paolo Bernardi and Sophia von Stockum. The permeability transition pore as a Ca2+ release channel: New answers to an old question. Cell Calcium (2012), vol. 52(1); p. 22-27
� Sophia von Stockum, Gabriella Mazzotta, Rodolfo Costa and Paolo Bernardi.
Expression of human Cyclophilin D in Drosophila melanogaster – impact on
regulation of the Drosophila mitochondrial Ca2+-induced Ca2+ release channel.
Manuscript in preparation
10
11 LIST OF ABBREVIATIONS
LIST OF ABBREVIATIONS
ΔΨm: mitochondrial membrane potential
ΔpH: pH gradient
Δμ�: electrochemical gradient
ANT: adenine nucleotide translocator
ADP: adenosine diphosphate
AIF: apoptosis inducing factor
Apaf-1: apoptotic protease-activating factor-1
ATP: adenosine triphosphate
BH3: Bcl-2 homology 3
CsA: Cyclosporin A
CsH: Cyclosporin H
Cyp-D: Cyclophilin D
cyt c: cytochrome c
CRC: calcium retention capacity
Diablo: direct inhibitor of apoptosis binding protein with low pI
DISC: death-inducing signaling complex
DNP: 2,4-Dinitrophenol
EGTA: ethylene glycol tetraacetic acid
endoG: endonuclease G
ER: endoplasmatic reticulum
FADH2: reduced form of flavin adenine dinucleotide
FBS: fetal bovine serum
FCCP: carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
HBSS: Hank’s balanced salt solution
hUCP2: human uncoupling protein 2
IAP: inhibitor of apoptotic proteins
IF1: inhibitor protein 1
IMM: inner mitochondrial membrane
MCU: mitochondrial Ca2+ uniporter
12
MDR: multi drug resistance
MnSOD: manganese superoxide dismutase
MOMP: mitochondrial outer membrane permeabilization
mtDNA: mitochondrial DNA
NADH: reduced form of nicotinamide adenine dinucleotide
NCLX: Na+/Ca2+ exchanger
NEM: N-ethylmaleimide
OMM: outer mitochondrial membrane
OSCP: oligomycin sensitivity conferring protein
PBR: peripheral benzodiazepine receptor
PBS: phosphate buffered saline
PCR: polymerase chain reaction
Pi: inorganic phosphate
PiC: phosphate carrier
PMCA: plasma membrane Ca2+-ATPase
PPIase: peptidyl-prolyl-cis-trans-isomerase
PT: permeability transition
PTP: permeability transition pore
Q: ubiquinone
ROS: reactive oxygen species
RR: ruthenium red
SDS: sodium dodecyl sulfate
Smac: second mitochondrial-derived activator of caspases
TMRM: tetramethyl rhodamine methyl ester
TNF: tumor necrosis factor
Ub0: ubiquinone 0
UCP 2: uncoupling protein 2
VDAC: voltage-dependent anion channel
XIAP: X-linked inhibitor of apoptosis proteins
YMUC: yeast mitochondrial unselective channel
13 INTRODUCTION
INTRODUCTION
14
15 INTRODUCTION
1 Mitochondria
Mitochondria are organelles found in the cytoplasm of every eukaryotic cell with the
exception of red blood cells and of amitochondrial eukaryotic organisms such as Giardia
intestinalis and Trachipleistophora homi1,2. Their most prominent roles are the supply of
energy in form of the high-energy molecule ATP and the regulation of cellular
metabolism. In addition, mitochondria are involved in a wide range of other processes,
such as Ca2+ homeostasis, cellular differentiation, control of cell cycle, cell growth and
cell death3.
1.1 Mitochondrial morphology
During live cell imaging it becomes immediately apparent that mitochondrial
morphology is far from static and that mitochondria are mobile and plastic organelles,
constantly changing their shape. They can undergo fission and fusion, events which in
mammals are regulated by the proteins OPA1, MFN1, MFN2 and DRP1(4), or move along
the cytoskeleton via specific motor proteins5, a process of critical importance in axons.
Thus, mitochondrial morphology varies widely among different cell types depending on
the balance between the rates of fission and fusion. In some cells they form long
filaments or chains as in fibroblasts. In others they remain fixed in one position where
they provide ATP directly to a site of high ATP consumption, e.g. in myofibrils.
Figure 1. Mitochondrial morphology in fibroblasts and cardiomyocytes. (A) Fluorescence imaging of reticular mitochondrial network in human fibroblasts (green) composed of filamentous tubules that frequently change shape
due to high rates of fission and fusion; from6. (B) Mitochondrial morphology in cardiomyocytes. Fluorescence live-cell
imaging of adult rat cardiomyocyte mitochondria (red). The mitochondria account for about 35% of total cell volume and are arranged longitudinally along the myofibrils at the sarcomeric A-band, providing the majority of ATP needed
for contraction and ion homeostasis; from7.
A B
16
Mitochondria possess their own genome consisting of a single circular DNA molecule8
encoding for 2 ribosomal RNAs (rRNAs), 22 transfer RNAs (tRNAs), and 13 polypeptides
(all of them components of the respiratory chain/oxidative phosphorylation system).
The majority of mitochondrial proteins, however, are encoded by the nuclear genome,
requiring import into the mitochondria following translation.
Figure 2. Cryotomogram from isolated rat liver mitochondrion. OMM: outer mitochondrial membrane, IMM: inner
mitochondrial membrane; modified from9.
Each mitochondrion has two highly specialized membranes, the inner and the outer
membrane, which have very distinct functions. Together they create two separate
mitochondrial compartments: the internal matrix and a narrow intermembrane space
(IMS). The inner mitochondrial membrane (IMM) is folded into numerous cristae, which
expand its surface area. The outer mitochondrial membrane (OMM) contains many
copies of the voltage-dependent anion channel (VDAC), which forms large aqueous
channels through the lipid bilayer and allows ions, metabolites and small molecules to
move between the cytoplasm and the mitochondria. Such molecules can enter the IMS,
but most of them cannot pass the impermeable IMM, which contains a high proportion
of the phospholipid cardiolipin, making it especially impermeable to ions. IMM
permeability is mediated by a variety of specialized membrane channels, transporters
and exchangers that make the latter selectively permeable to ions and small molecules
which are metabolized or required by the mitochondrial enzymes located in the matrix.
The IMM is a very good electric insulator and can keep a potential difference of -180
mV10. Proton pumping driven by electron flow through the respiratory chain constantly
17 INTRODUCTION
generates an electrochemical gradient (Δμ�H), which is composed of a membrane
potential difference (ΔΨ) and a proton concentration difference (ΔpH). The proton
gradient provides the driving force for ATP synthesis and for ion and metabolite
transport. The IMM contains also the energy transducing macromolecular complexes of
the respiratory chain.
1.2 Mitochondrial energy production
Living organisms require a constant input of energy to carry out movement like muscle
contraction, active transport of molecules and ions as well as the synthesis of
biomolecules from simple precursors. In most processes the carrier of free energy is
adenosine triphosphate (ATP). Ingested glucose is converted to pyruvate in a process
known as glycolysis, taking place in the cytoplasm of any cell. In this process only a very
small fraction of the total free energy potentially available from glucose is used to
synthesize ATP. The metabolism of the sugar is completed in the mitochondria, where
pyruvate is imported and eventually oxidized to CO2 and H2O through the combined
operation of the Krebs cycle, the respiratory chain and the FOF1 ATP synthase, whereby
15 times more energy is converted to ATP than in glycolysis. Initially, pyruvate is
metabolized to the intermediate acetylCoA and afterwards oxidized in the citric acid
cycle by a series of enzymatic reactions taking place in the mitochondrial matrix. End
products of this oxidation are CO2, which is released from the cell as waste, and the
activated electron carrier molecules NADH and FADH2, the sources of electrons for
transport along the respiratory chain. The enzymes of the electron transport chain are
located in the IMM and most of them are arranged into three large enzymatic
complexes, which as described later function also as H+-pumps. Each complex is
composed of electron carriers, associated with and held in close proximity by different
protein molecules. The three intermembrane complexes are linked by two mobile
electron carriers. The main purpose of making electrons pass through a chain of
electron carriers with increasing reduction potential (increasing affinity for electrons), is
to divide the energetically favorable reaction H2 + ½ O2 � H2O into small steps, so that
most of the energy released can be stored instead of being lost to the environment as
heat. Thus, the electrons start with high energy and gradually lose it as they pass along
18
the chain. The flow of electrons from the energy-rich molecules NADH and FADH2 to
the final acceptor O2 can be subdivided into the following steps.
Complex I: (NADH Dehydrogenase complex) accepts electrons from NADH and passes
them through a flavin and several iron-sulfur centers to ubiquinone (Q). The electrons
emerge in QH2, the reduced form of Q. This highly mobile hydrophobic molecule then
transfers its electrons to a second respiratory enzyme complex, the Cytochrome b-c1
complex. Complex I can be specifically inhibited by rotenone. Q also receives electrons
from FADH2 produced by the oxidation of succinate in the citric acid cycle by an enzyme
complex called Succinate Dehydrogenase (Complex II). Complex II is the only
respiratory complex which does not pump protons.
Complex III: (Cytochrome b-c1 complex) functions as a dimer. Each monomer contains
three hemes bound to cytochromes and an iron-sulfur protein. The complex accepts
electrons from Q and passes them on to cytochrome c (cyt c), a water-soluble
peripheral membrane protein, which is like Q a mobile electron carrier. It passes its
electrons to the Cytochrome Oxidase complex. Complex III can be specifically inhibited
by antimycin A which blocks the respiratory chain between cytochrome b and
cytochrome c1.
Complex IV: (Cytochrome Oxidase complex) is also composed of a dimer; each
monomer contains two cytochromes and two copper atoms. The complex accepts one
electron at a time from cyt c and passes them four at a time to oxygen, the ultimate
electron acceptor to form H2O. Complex IV can be specifically inhibited by cyanide,
which prevents respiration with all substrates.
The flow of electrons across the respiratory chain and the thereby released energy is
coupled to proton pumping across the IMM, from the matrix to the IMS. This generates
a proton gradient, which is largely contributed by the inside negative ΔΨ. The resulting
proton motive-force is the link between the electron flow in the respiratory chain and
the synthesis of ATP. The FOF1 ATP synthase (complex V) localized in the IMM uses the
19 INTRODUCTION
Δμ�H to drive the energetically unfavorable reaction between ADP and Pi to synthesize
ATP.
Structure of the ATP synthase (complex V)
The mitochondrial FOF1 ATP synthase is a multi-subunit protein localized in the IMM
and composed of a catalytic F1 and a membrane-bound FO part. The F1 region comprises
the subunits α, β (3 of each), γ, δ and ε whereas the FO region comprises subunits a, b, c
(multiple subunits, 8 in mammals), d, e, f, g, A6L and F611, 12. The F1 and FO parts are
connected by a central stalk formed by the subunits γ, δ, and ε as well as by a peripheral
stalk, comprised of the oligomycin sensitivity conferring protein (OSCP) and subunits b,
d, and F613. ATP synthesis is based on a rotary catalytic mechanism. H+ translocation
through the FO region induces rotation of the membrane-bound c-ring, which is
organized like a barrel within the membrane. Spinning of the c-ring induces the rotation
of the central stalk (which is attached to the c-ring) inside the α3β3 hexamer of the F1
part14. This process drives ATP synthesis by inducing conformational changes in three
catalytic nucleotide binding sites located at interfaces between α- and β-subunits11.
During rotation, the F1 region is held stationary relative to the FO region by the
peripheral stalk, a connection which is essential for the proper function of the enzyme15.
In absence of a proton gradient the ATP synthase can function in reverse, pumping
protons into the IMS and hydrolyzing ATP in order to create a mitochondrial membrane
potential (ΔΨm). Furthermore ATP synthase can associate with the inhibitor protein 1
(IF1) which inhibits hydrolysis of the enzyme. IF1 acts as a dimer and binds to the α-β
interfaces of two F1-ATPases via its N-terminal inhibitory sequence16. Binding of IF1
requires ATP and is favored by low pH and ΔΨm. The restoration of ΔΨm favoring ATP
synthesis displaces IF1 from the FOF1 ATP synthase17.
In eukaryotic mitochondria oligomycin can inhibit FOF1 ATP synthase, by binding to
subunit c18. It thereby blocks synthesis as well as hydrolysis of ATP and abolishes ADP-
stimulated respiration in intact mitochondria.
20
Figure 3. Schematic representation of the mitochondrial respiratory chain, composed of four multimeric complexes,
and of the ATP synthase (complex V). Shown are the set of reactions that transfer electrons from reduced cofactors to oxygen, obtaining water (yellow curved arrows). Electron transport between complexes I to IV is coupled to extrusion of protons from complexes I, III and IV into the intermembrane space (yellow straight arrows), creating an electrochemical gradient (Δμ�H) across the inner mitochondrial membrane (IMM). Protons then enter in the c-subunit (red straight arrow) of complex V, the ATP synthase, causing the ring of c-subunits to spin (black curved arrow) and driving the synthesis of ATP from ADP and Pi (red curved arrow). Some common specific inhibitors for complex I, III
and IV as well as for the ATP synthase are shown (black arrows on top); modified from19
.
1.3 Mitochondrial control of apoptosis
Mammalian cell death is most widely classified into two processes, apoptosis or
necrosis. Cells undergoing a sudden stress situation such as infection or exposure to
toxins die by necrosis resulting in loss of plasma membrane integrity, uncontrolled
release of cellular components and inflammation. On the contrary, apoptosis is a
genetically encoded and highly regulated form of cell death that governs normal body
sculpture, defense against pathogen invasion and developmental processes. Exposure
of the cell to an apoptotic stimulus leads to a series of morphological changes such as
rounding up of the cell, pseudopod retraction, cell shrinkage, chromatin condensation
and nuclear fragmentation20. Thus, apoptosis enables the body to eliminate a damaged
cell without affecting the neighboring environment. Its abnormal regulation is
associated with many human pathologies such as degenerative diseases (too much
apoptosis) or cancer (too little apoptosis). Until recently necrosis and apoptosis were
considered to be two distinct phenomena. However, there is now evidence that both
IMM
Intermembrane spaceRotenone Antimycin a Oligomycin
NADH NAD+
Succinate Fumarate
Complex I Complex II Complex III Complex IV Complex V
½ O2 H2O
ADP + Pi ATP
Cyanide
H+ H+H+
c
H+
Matrix
21 INTRODUCTION
processes can be interconnected and that necrosis can be initiated by death receptors
usually involved in apoptototic cell death in a process called necroptosis21.
The key player in the execution of apoptosis is a family of cysteinyl aspartate-directed
proteases called caspases. These enzymes are synthesized as inactive zymogens (called
pro-caspases) in healthy cells and can be activated by proteolytic cleavage upon
triggering by a diverse range of internal and external stimuli22. Upon receipt of
apoptotic stimuli, cells activate initiator caspases (such as caspase-2, -8, -9, and -10)
that, in turn, proteolytically activate effector caspases (such as caspase-3, -6, and -7).
Once active, effector caspases cleave different substrates, eventually leading to the
dismantling of the dying cell23. Activation of the initiator caspases may occur through
either an extrinsic or an intrinsic pathway.
Extrinsic pathway
The extrinsic pathway of apoptosis is mediated by activation of the so called death
receptors TNF, FAS or TRAIL. Upon binding of death ligands (such as members of the
tumor necrosis factor receptor superfamily) on the plasma membrane, conformational
changes in the receptors lead to the recruitment of adapter proteins on the cytoplasmic
side and thus the formation of the death-inducing signaling complex (DISC) and
subsequent activation of pro-caspase-8. Active caspase-8 in turn proteolytically
processes effector caspases (-3, -6 and -7) leading to further caspase activation events
which result in substrate proteolysis and cell death. Caspase-8 can also engage the
intrinsic apoptotic pathway through cleavage of the Bcl-2 homology 3 (BH3)-only
protein Bid24. Truncated Bid (tBid) translocates to the mitochondria, where it triggers
activation of the intrinsic apoptotic pathway by promoting mitochondrial outer
membrane permeabilization (MOMP) and release of apoptogenic proteins25.
Intrinsic pathway
The intrinsic pathway of apoptosis can be induced by many different stimuli such as
oxygen radicals, γ-irradiation, hypoxia or ischemia-reperfusion and converges on the
central death machinery at the mitochondria. The key event in the intrinsic pathway is
MOMP and release of mitochondrial apoptogenic proteins, usually located in the IMS,
22
into the cytosol. Once in the cytosol, apoptotic proteins such as cyt c, apoptosis
inducing factor (AIF), second mitochondria-derived activator of caspases (Smac)/direct
inhibitor of apoptosis binding protein with low pI (Diablo), and endonuclease G (endoG),
are able to initiate caspase-dependent or caspase-independent mechanisms that
promote apoptosis. In caspase-dependent signaling, the most critical apoptogen cyt c
binds to the adapter protein apoptotic protease-activating factor-1 (Apaf-1), changing
its conformational state and leading to its oligomerization as well as to the recruitment
of the effector caspase-9. The complex built of cyt c, Apaf-1 and caspase-9 is called
apoptosome and its formation is highly ATP-dependent26. The apoptosome in turn
leads to the downstream activation of other effector caspases and proteolytic cleavage
of target proteins. The function of active caspases can be blocked by the inhibitors of
apoptotic proteins (IAPs), whereas Smac/Diablo once released from the IMS binds to
and inhibits the effects of IAPs, thereby indirectly enhancing the activation of caspases.
In addition, AIF and endoG translocate to the nucleus where they induce nuclear
chromatin condensation and DNA fragmentation in a caspase-independent manner27.
23 INTRODUCTION
Figure 4. Intrinsic and extrinsic pathway of apoptosis. In the intrinsic apoptotic pathway, pro-apoptotic BH3 proteins of the Bcl-2 family are activated by diverse noxious stimuli, and inhibit anti-apoptotic proteins (Bcl-2 or Bcl-xL). Thus, Bax and Bak are free to induce mitochondrial permeabilization with release of cytochrome c, which ultimately results in formation of the apoptosome and subsequent activation of the caspase cascade. The outer membrane permeabilization can be induced by the permeability transition pore (PTP) as well. SMAC/DIABLO is also released after mitochondrial permeabilization and acts to block the action of inhibitors of apoptosis proteins (IAPs), which inhibit caspase activation. In the extrinsic apoptotic pathway, ligation of death receptors recruits the adaptor protein FAS-associated death domain (FADD) to form the death-inducing signaling complex (DISC). This in turn recruits caspase-8, which ultimately activates caspase-3, the key effector caspase. There is a cross-talk between the two pathways, which is mediated by the truncated form of Bid (tBid) that is produced by caspase-8-mediated Bid cleavage; tBid acts to inhibit the Bcl-2-Bcl-xL pathway and to activate Bax and Bak. Apaf1: apoptotic protease-activating factor 1, TNF: tumor
necrosis factor, TRAIL: TNF-related apoptosis-inducing ligand; modified from28.
The mechanisms by which MOMP occurs and mitochondrial apoptogenic factors are
released into the cytosol are still unresolved and different models which are not
mutually exclusive have been proposed. One of these models involves members of the
Bcl-2-family, which can be grouped into pro-apoptotic or anti-apoptotic proteins. All of
them contain one or more Bcl-2 homology (BH) domains, which are important for
heterodimeric interactions among the different members of the family29. Anti-
apoptotic Bcl-2 proteins (such as Bcl-2, Bcl-xL or Bcl-w) and pro-apoptotic Bcl-2 proteins
PTP
EXTRINSIC PATHWAY INTRINSIC PATHWAY
D
I
S
C
24
(such as Bax, Bak, or Bok/Mtd) display four BH domains. The proapoptotic BH3-only
proteins (such as Bid, Bad, Noxa or Puma/Bbc3), on the other hand, possess only a short
motif called the BH3 domain as their name indicates. Through their BH3 domain, these
proteins either inhibit anti-apoptotic proteins or stimulate oligomerization of the
multidomain proteins Bax and Bak leading to MOMP. Bax proteins can be found as
monomers in the cytosol. Upon activation the latter translocate to and insert into the
OMM30, while Bak is present in the OMM even if not activated31. Following activation,
Bax and Bak undergo conformational changes, oligomerize and form pores in the
OMM, inducing thus the release of the previously described apoptogenic proteins32.
This mechanism remains only poorly characterized and it seems unlikely that Bax-/Bak
channels are large enough to release the bigger pro-apoptotic proteins such as the
serine protease Omi-Htr2. Another mechanism leading to MOMP through opening of
the mitochondrial permeability transition pore (PTP) will be discussed in more detail
below.
2 Cellular Ca2+ homeostasis
Ca2+ ions are among the most important second messengers and play a key role in cell
signaling. Most cell types are able to translate the information obtained by a variety of
stimuli through an increase in intracellular [Ca2+] with highly defined spatial and
temporal patterns. This can be achieved by the storage of Ca2+ in specialized
compartments such as the endoplasmic reticulum (ER), by the low permeability of the
plasma membrane to ions and by the activity of the plasma membrane Ca2+-ATPase
(PMCA, pumping Ca2+ outside the cell) and of the Na+/Ca2+ exchanger (NCLX)33. Due to
these mechanisms the cell is able to keep very low cytoplasmic free [Ca2+] levels in
resting conditions (~100 nM). Upon stimulation, local changes in cytoplasmic [Ca2+] due
to fast release from the Ca2+ stores via highly selective channels can be sensed by Ca2+
dependent enzymes (such as kinases or phosphatases) or target proteins with direct
Ca2+-binding sites, that in turn induce specific cellular responses (e.g. contraction,
secretion, proliferation or cell death).
25 INTRODUCTION
Figure 5. Schematic representation of the Ca2+
homeostatic network between endoplasmatic reticulum,
mitochondria and cytosol. cADPr, cyclic ADP ribose receptor; CICR, calcium-induced calcium release channel; DAG, diacylglycerol; DHPR, dihydropyridine receptor; GPCR, G protein-coupled receptor; IP3, inositol triphosphate; PLC-β, phospholipase C-β; PM Ca
2+ channel, plasma membrane calcium channel; PMCA, plasma membrane channel pump;
RyR, ryanodine receptor; SERCA, sarco/endoplasmic reticulum Ca2+
ATPase; modified from33
.
2.1 The role of mitochondria
The first hint on the important role of mitochondria in Ca2+ handling was the
demonstration of Ca2+ accumulation in isolated energized rat kidney mitochondria half
a century ago34. Today it is known that mitochondria play a pivotal role in cellular Ca2+
homeostasis and that they are thereby involved in a wide field of physiological
processes such as buffering of cytoplasmic Ca2+ signals, excitation-contraction coupling
and induction of cell death. In healthy cells the mitochondrial matrix [Ca2+] is low. When
Ca2+ is released from the Ca2+ stores into the cytoplasm, microdomains of high [Ca2+]
(10-20µM) can transiently form in regions of close proximity between mitochondria and
Ca2+ channels of the ER or the plasma membrane35. Mitochondria in these regions
rapidly accumulate Ca2+ and then gradually release it when plasma membrane ion
pumps have lowered the cytoplasmic free [Ca2+], thus amplifying and sustaining signals
arising from cytoplasmic [Ca2+] increases. Furthermore, mitochondrial Ca2+ uptake can
26
profoundly influence cell survival, as excess matrix [Ca2+] can initiate cell death through
opening of the PTP (as discussed below). Thus, the mechanisms controlling cellular and
mitochondrial Ca2+ homeostasis, metabolism and bioenergetics have to be tightly
integrated in the overall cellular Ca2+ homeostatic network36.
2.2 Mitochondrial Ca2+ influx and efflux mechanisms
Ca2+ uptake into respiring mitochondria is an energy dependent, electrophoretic
process driven by the Ca2+ electrochemical gradient Δμ�Ca, favored by the inside-
negative ΔΨm and mediated by the mitochondrial Ca2+ uniporter (MCU). In the last four
decades the MCU has been characterized in terms of thermodynamic properties and
inhibitor specificity (with ruthenium red and lanthanides being the most potent
inhibitors) and was recently shown to be a highly selective, low conductance channel by
electrophysiology37. In 2011 two groups independently identified a 40kD protein with
two transmembrane domains to be the MCU38, 39. The influx of Ca2+ via the MCU is
charge-compensated by increased H+ pumping of the respiratory chain, resulting in
increased matrix pH, which lowers the ΔΨm and prevents further uptake of Ca2+(40).
Uptake of substantial amounts of Ca2+ therefore requires buffering of matrix pH (to
allow regeneration of the ΔΨm) as well as buffering of matrix Ca2+ (to prevent the
buildup of a Ca2+ concentration gradient)41-43. Buffering of matrix pH is achieved by the
simultaneous uptake of protons and anions via diffusion of the undissociated acid
through the IMM (as in the case of acetate), of CO2 (which then regenerates bicarbonate
and H+ in the matrix) or through transport proteins (like the H+–Pi symporter)44. The
buildup of a Ca2+ concentration gradient may be prevented by the cotransport of Pi.
Indeed, under physiological conditions the parallel accumulation of Pi and Ca2+ leads to
the formation of a Ca2+/Pi complex in the matrix which effectively buffers matrix free
[Ca2+]45. However, the [Ca2+] inside the mitochondrial matrix is not exclusively dictated
by Δμ�Ca, but is rather governed by a kinetic steady state between Ca2+ influx via the
uniporter and Ca2+ efflux by antiporters (Na+/Ca2+ and H+/Ca2+ exchanger) that extrude
Ca2+ from the matrix using the concentration gradients of H+ and Na+. The Na+/Ca2+
exchanger NCLX, which mediates Ca2+ efflux with a stoichiometry of 3 Na+- 1 Ca2+, has
been recently identified at the molecular level46, whereas the Na+-insensitive Ca2+
27 INTRODUCTION
extrusion pathway via a putative H+/Ca2+ exchanger has been studied only functionally
in isolated mitochondria and has a predicted stoichiometry of 3 H+-1 Ca2+ (47).
Figure 6. Schematic representation of mitochondrial Ca2+
uptake and efflux mechanisms. Ion fluxes are indicated by arrows. Red arrow, Ca
2+; blue arrow, H
+; yellow arrow, Na
+. ETC: electron transport chain; NCLX: Na
+/Ca
2+ exchanger;
HCX: H+/Ca
2+ exchanger; PTP: permeability transition pore; UCP2/3: uncoupling protein 2/3; VDAC: voltage-dependent
anion channel; IMS: intermambrane space; MCU: mitochondrial Ca2+
uniporter; MICU1: mitochondrial Ca2+
uptake 1; modified from
48.
2.3 The problem of Ca2+ overload: a constant threat for mitochondria
The coupling of Ca2+ uptake with Ca2+ efflux in energized mitochondria on distinct
pathways allows the regulation of both cytoplasmic and matrix [Ca2+]. However, a
kinetic imbalance is apparent because the Vmax of the MCU is about 1400 nmol Ca2+ per
mg protein per min while the combined Vmax of the efflux pathways is about 20 nmol
Ca2+per mg protein per min. What is the reason for such an imbalance? The rate of Ca2+
uptake via the MCU is a steep function of extramitochondrial [Ca2+]49. If mitochondria
could release Ca2+ at a comparable rate this would increase extramitochondrial [Ca2+],
stimulate Ca2+ uptake by the MCU and increase overall Ca2+ cycling resulting in energy
dissipation50. Thus, net Ca2+ efflux through stimulation of the efflux pathways would
have a high energetic cost for the cell, which can be avoided with the previously
described low Vmax and early saturation of the efflux pathways. However, this energy-
saving strategy exposes mitochondria to another dangerous problem. According to the
above described kinetic model, increase of extramitochondrial Ca2+ goes along with
matrix
IMS
ΔΨ -180mV
Ca2+
HCX
3 3
28
increase of matrix Ca2+ when the rate of Ca2+ uptake exceeds that of the efflux
pathways and thus mitochondria are constantly exposed to the danger of Ca2+ overload.
To prevent this scenario mitochondria need a system to achieve transient, fast and
regulated Ca2+ release in situations of high matrix [Ca2+]. It was hypothesized that this
mechanism could be provided by transient openings of the PTP and there is more and
more evidence that this plays a relevant role in in vivo Ca2+ homeostasis and signalling
processes, as will be discussed more in detail below.
3 The permeability transition pore (PTP)
The mitochondrial permeability transition (PT) describes a process of Ca2+-dependent,
regulated increase in the permeability of the inner mitochondrial membrane to solutes
with molecular masses below approximately 1500 Da. This event, which plays a major
role in cell death, is due to the opening of the mitochondrial PTP, a high-conductance
inner membrane channel. The PTP was discovered and studied mostly in mammals
where it was shown to play a role in different cellular processes, depending on the open
time of the channel. PTP opening causes collapse of ΔΨm and Ca2+ release through the
pore itself, an event that for short open times may be involved in physiological Ca2+
homeostasis51 and might play a role in cell signaling52. Prolonged opening of the PTP, on
the other hand, causes stable depolarization, loss of ionic homeostasis, depletion of
pyridine nucleotides and respiratory inhibition. During the PT ions and osmotically
active molecules (up to 1500 Da) can enter the mitochondria and consequently lead to
influx of water into the matrix and thus mitochondrial volume increase. Matrix swelling
in turn can lead to rupture of the OMM, release of apoptogenic proteins such as cyt c
and cell death via apoptosis or necrosis depending on a variety of additional factors,
among which cellular ATP and Ca2+ levels play a major role53. For a long time the PTP
was considered to be an in vitro artifact of little pathophysiological relevance. However,
the role of the PTP in disease has been reevaluated in the context of both programmed
and accidental cell death39 and there is increasing evidence that it might function as a
Ca2+ release channel in physiological Ca2+ homeostasis, as will be discussed below.
29 INTRODUCTION
Figure 7. Mechanisms of mitochondrial permeabilization and release of intermembrane space proteins due to the
opening of the permeability transition pore. Opening of the permeability transition pore (PTP) can be triggered by different stimuli and results in loss of mitochondrial membrane potential (Δψm), decreased ATP production and entry of solutes and water into the mitochondrial matrix. This causes mitochondrial swelling, outer mitochondrial membrane (OMM) rupture and release of apoptogenic proteins, such as cytochrome c (cyt c) from the intermembrane space into the cytosol. Cyt c in turn leads to formation of the apoptosome and subsequent activation
of the caspase cascade, thus inducing cell death. Cyp-D: Cyclophilin D; modified from54.
3.1 Features and regulation of the PTP in mammals
Most classical studies of the PT were carried out in mitochondria obtained from
mammalian cells or tissues. These studies allowed a thorough characterization of the
functional properties and regulation of the putative channel, but its molecular nature
remains still elusive. The transition between the “open” and “closed” state of the PTP
can be modulated by many different compounds, ions or conditions. These PTP
effectors can be subdivided into inducers, that increase the probability of the pore to
open; and inhibitors, that increase the probability of the pore to close. Perhaps the
single most important factor, which is essential for opening of the PTP and therefore is
called a “permissive factor”, is matrix Ca2+. Importantly, all the other divalent metals,
such as Mg2+, Mn2+ and Sr2+ instead decrease the PTP open probability. Another
important modulator of the PTP is matrix pH, with an optimum for PTP opening at pH
7.4. More basic as well as more acidic pH desensitizes the PTP to opening55. The PTP is a
voltage-dependent channel, in the sense that a decrease in ΔΨm favors PTP opening,
whereas a high inside-negative ΔΨm tends to stabilize the pore in the closed
conformation56. This led to the hypothesis that a specific sensor, which is able to
solutes
and water
cyt c
30
perceive the threshold potential necessary to open the PTP, does exist. Many PTP
modulators appear to modify the threshold potential, bringing it closer (inducers) or
moving it further away (inhibitors) from the resting potential50. Thus, an inducer brings
the threshold potential needed for PTP opening closer to the resting potential, and
makes mitochondria more susceptible to PTP opening even after slight depolarizations.
Inhibition of PTP can also be observed with bongkrekate57, whereas atractylate opens
the pore58. Since atractylate and bongkrekate are selective inhibitors of the adenine
nucleotide translocase (ANT), these results led to the suggestion that the PTP may be
entirely or partially formed by the ANT59, an issue that will be discussed below.
The PTP can be directly regulated by electron flux within complex I of the respiratory
chain, with an increased open probability when flux increases60. This led to the
discovery that quinones can modulate the PTP, with some of them acting as inhibitors
(such as ubiquinone 0 (Ub0) or decylubiquinone) and others as inducers (such as 2,5-
dihydroxy-6-undecyl-1,4-benzoquinone). A third class of PTP-inactive quinones (such
as ubiquinone 5) are able to counteract the effects of both inhibitors and inducers.
However, despite a large number of studies, the exact relationship between quinone
structure and effect on the pore remains unsolved61.
Opening of the PTP is strongly favored by an oxidized state of the pyridine nucleotides
NADH and NADPH as well as of critical thiol groups at distinct matrix or membrane
sites. Both of these effects can be reversed by reducing agents62, 63. The interconversion
between dithiol and disulfide groups correlates with the redox state of glutathione,
suggesting that there is a redox equilibrium between the dithiols and matrix
glutathione. This finding explains the effect of thiol reacting agents such as N-
ethylmaleimide (NEM)64, 65 and monobromobimane66 on the pore.
Inorganic phosphate (Pi) is a powerful PTP inducer in mammalian mitochondria,
whereas it has an inhibitory effect in yeast mitochondria. As Pi is also taken up following
Ca2+ uptake into the matrix, where it leads to the formation of a Ca2+-Pi complex, an
increased threshold of the PTP to Ca2+ should be expected when Pi is present, due to its
lowering effect on free matrix [Ca2+]. The unexpected inducing effect of Pi on the PTP
has been explained by the fact that an increase of Pi also produces a decrease in matrix
free [Mg2+] (a PTP inhibitor), as well as buffering of matrix pH at ~7.2, and it may
31 INTRODUCTION
generate polyphosphate67, all of which would favor PTP opening. Recently, our group
demonstrated that Pi can also act as an inhibitor of the PTP in case of genetic ablation
of the matrix peptidyl-prolyl-cis-trans-isomerase (PPIase) Cyclophilin D (Cyp-D) or its
displacement from the pore by its specific inhibitor Cyclosporin A (CsA). We
hypothesized that Cyp-D might mask a Pi-regulatory site, which becomes only
accessible when Cyp-D is detached from the pore68.
Figure 8. Modulation of the permeability transition pore by Cyclophilin D and Phosphate in mammalian
mitochondria. The permeability transition pore (PTP) displays a higher probability of opening (right) when it binds to Cyclophilin D (Cyp-D); treatment with Cyclosporin A (CsA) displaces Cyp-D and unmasks a cryptic site for inorganic Phosphate (Pi) (center); if the Pi concentration is sufficiently high, Pi binding decreases the probability of pore opening
(left), in a reaction that can be readily reversed if the Pi concentration decreases; from69.
Opening of the PTP is inhibited by the immunosuppressive drug CsA70 through the
binding to its matrix target CyP-D. CsA acts on Cyp-D by inhibiting its PPIase activity,
but whether this is essential for the modulating effect of Cyp-D on the PTP is still
unclear71. Likewise (and at variance from immunosuppression), the effect of CsA does
not involve inhibition of calcineurin72. However, CsA cannot be regarded as a true PTP
blocker but rather as a desensitizer, as pore opening still occurs in presence of CsA, even
if the threshold Ca2+ needed for PTP opening increases two to three-fold. Furthermore,
sensitivity to CsA highly depends on the expression level of Cyp-D and is thus tissue-
and cell type-specific. Tissues or cell lines expressing low levels of Cyp-D were shown to
be less sensitive to CsA but more sensitive to another potent PTP inhibitor, rotenone73.
On the other hand, high expression levels of Cyp-D correlate with a high sensitivity to
32
CsA and a low sensitivity to rotenone. Inhibition of the PTP by rotenone requires Pi in a
striking analogy with the effect of CsA, suggesting that both might act on the same
binding site. Thus, inhibition of complex I by rotenone and detachment of Cyp-D by CsA
might affect the PTP through a common mechanism73.
Figure 9. Modulators of the permeability transition pore in mammals. All modulators are grouped in inhibitors which promote the closed and inducers which promote the open state of the pore, signs denote transmembrane electrical potential, Ub0: Ubiquinone 0, Cyp-D: Cyclophilin D, CsA: Cyclosporin A, ΔΨm: mitochondrial membrane potential;
modified from74
.
3.2 Structure
Many hypotheses on the molecular nature of the PTP have been put forward over the
years. Based on many pharmacological studies, the PTP has been supposed to be a
multiprotein-channel created by defined components.
+ + + + + + + +
_ _ _ _ _ _
intermembrane space
matrix
inhibitorsinhibitorsinhibitorsinhibitors
inducersinducersinducersinducers
openopenopenopenclosedclosedclosedclosed
Inhibitors: Inducers:
Ub0 2,5-dihydroxy-6-undecyl-1,4-
benzoquinone
Mg2+ matrix Ca2+
NAD(P)H NAD(P)+
-SH HS- -S-S-
GSH GSSG
ADP, ATP, bongkrekate atractylate
Pi (in presence of CsA or in absence of
Cyp-D)
Pi
high ΔΨm low ΔΨm
matrix pH < 7.4, or > 7.4 matrix pH ~ 7.4
CsA
rotenone
33 INTRODUCTION
VDAC: (voltage dependent anion channel, located in the OMM). Several data led to the
hypothesis that VDAC is a component of the PTP. Purified VDAC when incorporated in
phospholipid bilayer membranes forms channels with size and electrophysiological
properties similar to those of the PTP75, 76. In addition it has been found that VDAC can
be modulated by some of the stimuli that regulate the PTP, e.g. Ca2+, NADH,
glutamate77-79, and binding of hexokinase II80. In mammals there are three VDAC
isoforms (VDAC 1, 2 and 3), and each of them is able to form channels when
incorporated in phospholipid bilayers81. However, characteristics of permeability
transition have been studied in VDAC1-/- mice, but the properties of the PTP in mutants
and wild-type mice were identical82. Studies in cells lacking all of the three isoforms
finally led to the conclusion that VDAC is not essential for the mitochondrial PT83.
ANT: The adenine nucleotide translocator was supposed to be a component of the
pore, as the PTP can be modulated by inhibitory ligands of ANT and by adenine
nucleotides themselves84. Studies in ANT knock-out mitochondria isolated from mouse
liver, however, showed that ANT as well is not essential for PTP formation. ANT-/-
mitochondria undergo a PT which is Ca2+- and oxidant-dependent as well as CsA-
sensitive. This indicates that ANT is neither the binding partner of Cyp-D nor it is the
target for the oxidants85. Furthermore, isolated hepatocytes of wild-type and ANT
knock-out mice show an identical response to death receptor-mediated activation of
apoptosis. Thus, experimental data based on genetic ablation of the relevant proteins
support the conclusion that also ANT is not an essential component of the PTP.
Phosphate carrier: The phosphate carrier (PiC) is a member of the mitochondrial
carrier family and promotes the transport of Pi across the IMM. Uptake of Pi into the
mitochondria is essential for the production of ATP from ADP. Different studies
hypothesized a role for PiC in the PTP composition due to the fact that some inhibitors
of the PTP such as NEM65, Ub086 and Ro 68-340087, are also PiC inhibitors88, 89. However,
these studies were performed with de-energized mitochondria incubated in the
presence of 40 mM Pi, conditions that are far from physiological. Thus, it is
questionable how relevant the obtained results are to an in vivo situation. Another
critical point is the inseparable relationship between Ca2+ and Pi uptake in
34
mitochondria. Inhibition of PiC by NEM in respiring mitochondria blocks Pi uptake and
consequently limits Ca2+ uptake to amounts that may be below the threshold level for
PTP opening42. Thus, the effect of PTP inhibition due to decreased Pi or decreased Ca2+
uptake is hard to sort out. Furthermore, the ubiquinone analogues Ub0 and Ro 68-3400
desensitize the PTP to Ca2+ even when Pi is replaced by arsenate or vanadate68.
Whether the PiC is a component of the PTP should be addressed by knock-out
approaches as used for studying the role of ANT and VDAC. A recent attempt to
elucidate the role of PiC in pore formation by siRNA down-regulation of both splice
variants (PiC-A and PiC-B) failed, since maximal knock down efficiency was 65-80% and
the remaining protein was sufficient to maintain maximal rates of Ca2+ uptake without
any detectable decrease in PTP opening89.
Cyclophilin D: The regulatory role of the mitochondrial peptidyl-prolyl-cis-trans-
isomerase Cyp-D on the PTP has been discovered through the finding that the
immunosuppressant drug CsA, a potent inhibitor of the intrinsic apoptotic pathway,
also inhibits the PTP at concentrations very similar to those needed to inhibit the
enzymatic activity of Cyp-D72, 90. Several genetic studies have demonstrated that Cyp-D
is a regulator of the PTP, sensitizing it to Ca2+, rather than being a component of the
pore68, 91, 92. Further details on structure and function of Cyclophilins and in particular
Cyp-D will be provided in chapter 4.
Additional proteins may play a regulatory role on the PTP. Amongst these the anti-
apoptotic and pro-apoptotic proteins of the Bcl-2-family in the OMM93, mitochondrial
creatine kinase (which produces ATP from ADP by converting creatine phosphate to
creatine)94, mitochondrial hexokinase (which catalyze the first step of glycolysis)95, 96
and the peripheral benzodiazepine receptor (PBR or TSPO), located in the OMM and
involved in steroidogenesis97.
3.3 The PTP as a Ca2+ release channel
Besides its well accepted role in cell death induction, the PTP was hypothesized to be a
Ca2+ release channel whose transient opening protects mitochondria from Ca2+
overload. This idea could be corroborated through recent studies in isolated
35 INTRODUCTION
cardiomyocytes, adult cortical neurons and Cyp-D KO mice. In 1992, R. Altschuld et al.
demonstrated that CsA significantly increases net Ca2+ uptake and decreases Ca2+ efflux
in isolated cardiomyocytes, without having any impact on cell morphology or viability98.
The effect of CsA was concentration dependent and specific to mitochondria, as ATP-
dependent Ca2+ uptake by the sarcoplasmatic reticulum was not affected. This was the
first piece of evidence that the PTP might contribute to Ca2+ cycling in the mitochondria
of functional cardiomyocytes and that reversible pore opening may be a normal process
in heart cells. However, a direct role for the PTP in regulation of mitochondrial total
Ca2+ in situ remained controversial, as Eriksson et al. demonstrated that fluxes of Ca2+,
Mg2+ and adenine nucleotides in perfused rat livers following hormonal stimulation
were unaffected by CsA99. The authors concluded that regulation of mitochondrial ion
and metabolite homeostasis is independent of the PTP. Two recent publications based
on a knock-out mouse model lacking the Ppif gene encoding for the mitochondrial Cyp-
D do provide clear support for a role of the PTP in Ca2+ homeostasis100, 101. Barsukova et
al. treated adult cortical neurons from wild type and Ppif−/− mice with either ATP (to
activate P2Y purinergic receptors) or with depolarizing concentrations of KCl (to open
plasma membrane voltage-dependent Ca2+ channels), and demonstrated that both
stimuli cause a robust increase of both cytosolic and mitochondrial [Ca2+] that is
indistinguishable in neurons of the two genotypes101. Application of the two stimuli
together, however, resulted in much higher levels of mitochondrial [Ca2+] in the Ppif−/−
neurons, suggesting that the threshold for PTP activation had been reached in the wild
type but not in the Cyp-D null mitochondria in situ. The higher resistance to
mitochondrial Ca2+ overload and thus the capacity to blunt in vivo cytoplasmic Ca2+
increases might explain the neuroprotective effect of Cyp-D ablation in many
neurodegenerative disease models and underlines the high physiological importance of
transient, rather than persistent PTP opening102-104. The implication of Cyp-D and the
PTP in pathologic conditions in vivo was further investigated by Elrod et al. Cyp-D KO
mice were more susceptible to cardiac hypertrophy, fibrosis and reduction in
myocardial function upon treatment with stimuli such as transaortic constriction,
overexpression of Ca2+/calmodulin-dependent protein kinase IIδc and swimming
exercise100. Myocardial dysfunction was not due to altered cell viability indicating an
additional role of the PTP beyond cell death induction. Indeed, the authors showed that
36
heart mitochondria lacking Cyp-D had higher resting Ca2+ levels resulting in metabolic
alterations such as activation of Ca2+-dependent dehydrogenases and increased glucose
oxidation, thus limiting the heart’s ability to maintain contractility during stress
situations. This was the first in vivo study demonstrating that the PTP is an important
regulator of Ca2+ homeostasis and of signaling events critically involved in metabolic
adaptation to disease states such as heart failure. For further discussion and more
detailed analysis of this topic see Publication 3.
3.4 The PTP in other species: a channel conserved through evolution?
Classical studies on the PTP were carried out mostly in mitochondria obtained from
mammals, although permeability changes have also been described in yeast
mitochondria105-109. However, due to the increasing interest on the PT in cell death,
studies have emerged also in mitochondria from other organisms, e.g. plants110-114,
fish115, 116 and amphibians117, 118. Until recently, though, it was not clear whether the
permeability changes observed in these organisms can be ascribed to the same
molecular events. Our recent findings in Drosophila might bridge the gap between the
pore of yeast and that of mammals, and support our proposal that channels in different
species actually possess unifying features119, as will be described below.
3.5 Ca2+ transport and PT in yeast mitochondria
Cell signaling roles of Ca2+ are less developed in lower eukaryotes, explaining why
mitochondria may be less critical in the maintenance of Ca2+ homeostasis. In addition,
ATP production in yeast seems to be independent of the regulation of Ca2+(120). This can
be explained by the fact that mitochondria from most yeast strains do not possess a
rapid Ca2+ uptake system as the MCU106, 121 (although there are strain-specific
differences, as Endomyces magnusii does have a Ca2+ uniporter122) or a Na+-stimulated
Ca2+ release pathway as NCLX. Nevertheless, they do contain a mitochondrial Ca2+:2H+
antiporter extruding Ca2+ from the matrix, which is highly active in presence of free
fatty acids123, suggesting that matrix Ca2+ may serve some regulatory role.
Yeast mitochondria also possess a fast Ca2+ release channel called yeast mitochondrial
unselective channel (YMUC), which can be opened by respiration or nucleotides and has
37 INTRODUCTION
similar electrophysiological properties as the mammalian PTP105-109, 124. For a long time
yeast was considered to be a poor model for studying the PTP, as the regulation of this
channel seemed to be too different, particularly because it is inhibited rather than
activated by Pi, and insensitive to CsA107. Several new results, however, suggest that the
PTP of yeast and mammals may be closer than previously thought. One issue concerns
the Ca2+-dependence of YMUC in the presence of the Ca2+ ionophore ETH129, which
allows electrophoretic matrix Ca2+ accumulation in yeast mitochondria106. A recent
study shows that in optimized conditions, i.e. using low concentrations of Pi (an
inhibitor of the yeast pore), the opening of the channel becomes Ca2+-dependent109. The
opposing effects of Pi (which is an inducer of the mammalian PTP and an inhibitor of
the yeast pore) could be recently explained in a study showing that Pi may become an
inhibitor in mammalian mitochondria that are treated by CsA or in which Cyp-D had
been genetically ablated68. We suppose that Cyp-D is masking an inhibitory Pi binding
site which becomes accessible only when Cyp-D is removed. Thus, we hypothesize that
the yeast mitochondrial cyclophilin CYP3125 may not be able to bind the PTP, and
thereby to hinder the binding site for Pi. This scenario would explain the inhibitory
function of Pi as well as the lack of CsA-sensitivity in yeast. Additional points are the
lack of effect of several inducers of the mammalian PTP like carboxyatractylate
(inhibitor of the ANT), ligands of the PBR, and prooxidants in yeast107. However, some of
these differences might depend on experimental conditions as e.g. the dithiol
crosslinker phenylarsine oxide, one of the most important PTP-inducers, is able to
sensitize the yeast pore to Ca2+(126). Based on these observations, we believe that the
yeast and mammalian PT may be the expression of very similar events, although they
differ in modulation through mechanisms that will be fully understood only after the
molecular nature of the PTP is defined.
For further description of PT in other species and comments on the conservation of the
PTP during evolution see Publication 2.
38
4 Cyclophilins
The cyclophilins are a family of highly conserved PPIases with a crucial role in protein
folding. The peptide bonds of any protein can exist in two different isomeric forms, cis
or trans. Protein folding as well as refolding processes following cellular membrane
traffic require isomerization and the interconversion between the cis and the trans form
of prolines relative to the nascent polypeptide chain is catalyzed by cyclophilins and
other PPIases. All cyclophilins share a common domain of about 109 amino acids, the
cyclophilin-like domain (CLD), surrounded by domains unique to each member of the
family that are associated with subcellular compartmentalization and functional
specialization127. All cyclophilins can bind the immunosuppressant drug CsA. The
cytoplasmic Cyclophilin A (Cyp-A) is the main intracellular receptor for CsA128. The
immunosuppressive action of CsA is carried out via a ternary complex between CsA,
Cyp-A and calcineurin, a calcium-calmodulin-activated serine/threonine-specific protein
phosphatase. The CsA-Cyp-A complex inhibits calcineurin preventing
dephosphorylation, hence nuclear translocation of the nuclear factor of activated T cells
(NFAT), thus preventing the transcription of genes encoding cytokines129.
4.1 Cyclophilin D
Cyp-D, which in the mouse is encoded by the Ppif gene, possesses a mitochondrial
targeting sequence and is imported into the mitochondrial matrix upon translation.
Cyp-D has a series of binding partners inside mitochondria. In the matrix it interacts
with a complex chaperone network involving Hsp90 and its related molecule TRAP-1130.
Capturing of Cyp-D to this complex makes it no longer available for binding to, and
inducing, the PTP, which might be a strategy to protect from cell death. Treatment of
tumor cells with shepherdin, an Hsp90 antagonist, leads to replacement of Cyp-D from
the Hsp90–TRAP-1–Cyp-D complex and selective killing of tumor cells130. Another
target of Cyp-D is the FOF1-ATP synthase, as recently documented in bovine heart and
liver mitochondria131. Giorgio et al. demonstrated that Cyp-D binds to the lateral stalk of
the enzyme, forming a complex with the OSCP, b, and d subunits, and that this binding
is favored by Pi. Association of Cyp-D to the FOF1-ATP synthase decreases the ATPase
activity while treatment with CsA increases the latter and displaces Cyp-D from the
39 INTRODUCTION
ATP synthase. A recent study also demonstrated a CsA-sensitive interaction of Cyp-D
with the anti-apoptotic protein Bcl2132.
Cyp-D binds to the IMM in a process that is associated with PTP opening, promoted by
increased intramitochondrial levels of Ca2+ and/or reactive oxygen species and inhibited
by CsA. The first pharmacological tool used to demonstrate the relationship between
Cyp-D and the PTP was CsA. Later this interaction was confirmed by other Cyp-D
ligands such as sanglifehrin A, NIM-811, Debio-025 and antamanide133-136. However, only
after the generation of Ppif-/- mice lacking Cyp-D, a final evidence for Cyp-D in PTP
regulation could be provided. Several studies analyzed fibroblasts, thymocytes and
hepatocytes isolated from Ppif-/- mice and evaluated in particular the response to
different apoptotic stimuli91, 102, 137, 138. Basso et al. showed that the PTP in Ppif-/-
mitochondria still forms, consistent with its role as a pore regulator, but not as a
structural component. The propensity of PTP opening in Cyp-D null mitochondria is
strikingly reduced in that the opening requires about twice the Ca2+ load necessary to
open the PTP in wild type mitochondria. PTP opening in Ppif-/- mitochondria was
insensitive to CsA, as expected. Studies in cells lacking Cyp-D showed that they were
more resistant to oxidative stress and increased cytoplasmic Ca2+(102). On the other
hand, increased Cyp-D expression in a neuronal cell line139 and in mitochondria from rat
hearts with volume overload-induced compensated hypertrophy140 were more
susceptible to PTP opening and cell death. Recently, Basso et al. have shown that the
desensitizing effect of Cyp-D ablation or CsA treatment on the pore is only present
when Pi is used, but not when the latter is replaced by its analogues arsenate or
vanadate. As already mentioned, these results suggest that when Cyp-D does not bind
to the PTP (because of genetic ablation or of the binding to CsA) Pi can bind to an
inhibitory site on the pore thereby delaying pore opening68.
There is a striking analogy between the regulation of the PTP and the ATP synthase by
Cyp-D and CsA. Indeed, Pi favors binding of Cyp-D to ATP synthase and PTP opening,
while CsA promotes Cyp-D unbinding from the ATP synthase and PTP closure. Whether
this is due to a link between the two processes is currently under investigation in our
laboratory. Our recent studies have shown that the PTP might form from dimers of the
ATP synthase (Giorgio et al, submitted).
40
5 The fruit fly Drosophila melanogaster
The ecdysozoan arthropod Drosophila melanogaster belongs to a sub-species of the
Drosophilidae, dipteran insects found all over the world. The species is known generally
as the common fruit fly. The life cycle of Drosophila varies with temperature, as is the
case for many ectothermic species. At 25°C the developmental time (egg to adult) is
about 10 days. Females lay about 400 eggs into rotting fruit or other suitable material.
The eggs, which are about half a millimeter long, hatch after about one day into a
worm-like larva. The larva grows for about 4 days, molting at day 1, day 2, and day 4
after hatching (first, second and third instar larva). After another two days the larva
molts one more time to form an immobile pupa and undergoes a four-day-long
metamorphosis, in which the body is completely remodeled to give rise to the adult
winged form. The life cycle is concluded with the hatching from the pupal case after
which the fly becomes fertile within about 12 hours.
Figure 10. Life cycle of Drosophila melanogaster. One day after fertilization the larva hatches. First, second, and third instar are larval stages, each of them ending with a molt. In the pupal stage most of the larval tissues are destroyed and replaced by adult tissues derived from the imaginal discs that were growing in the larva. Times are indicative for the life cycle of flies maintained at 25°C; modified from
141.
pupa
41 INTRODUCTION
Since during evolution arthropods separated from vertebrates more than 600 million
years ago142, 143, Drosophila might be supposed to be very different from humans with
respect to genetics and cellular pathways. However, comparative analysis of the
genome of Drosophila and humans revealed striking similarities in the structural
composition of individual genes144 and Drosophila quickly became an important tool for
genetic, molecular and behavioral studies.
5.1 Drosophila as a model organism
Since T.H. Morgan in 1910 demonstrated the chromosome theory of heredity in the
fruit fly Drosophila, this organism has played an important role in the development of
modern biology, in particular in the area of genetics. Today it is one of the most
important model organisms in studies of development and differentiation145, aging146,
cell cycle147, transcriptional and translational control148, signaling pathways149, sensorial
perception150 , neurodegenerative diseases151 and circadian rhythms152.
Moreover Drosophila melanogaster has been one of the first organisms to be sequenced
in its entirety153, and a database with all nuclear and mitochondrial encoded genes is
available154. The Drosophila genome contains a large number of human orthologs,
which include conserved molecules and pathways of key cellular processes155. These
findings quickly made Drosophila an important system to model human diseases156.
Research projects focused on neurodegenerative diseases157, cancer158, cardiac
pathologies159, age-associated dysfunction160 and recently also on mitochondrial
diseases161-163 have emerged.
Compared to higher organisms Drosophila offers some attractive features as a model
organism; these are especially suited for studying complex biological processes.
Drosophila is ideally tractable at the genetic, biochemical, molecular and physiological
levels. First of all the flies can be easily maintained in large numbers in stocks and
populations without specialized instrumentation. Drosophila has a short life-cycle
resulting in the production of a large number of progeny over a short, 10-day
generation period155. Other model organisms such as the mouse require a longer, 21-
day gestation time and produce a smaller number of progeny. For the purpose of
genetic screens, Drosophila provides two benefits in that its genome is comprised of
42
only 4 pairs of chromosomes, as opposed to 16 in the yeast strain Saccharomyces
cerevisiae, or 23 in humans, thus simplifying genetic inheritance. The second advantage
is that mutants can be created quite easily by molecular techniques using P-element
transposons164, site specific recombination to knock-in and knock-out specific genes, or
RNA-interference to knock-down gene expression165. In recent years many different
tools to trigger gene expression or repression have been developed. Furthermore, the
use of X-rays and other mutagenic agents makes it possible to generate large
collections of mutant stocks. Several key features of Drosophila, such as the compound
eye, provide unique methods for studying mutational effects by simple visual
observation of the resulting phenotype155. Thus, Drosophila provides an excellent model
organism through the compromise between simple cultivation, genetics and
phenotypic scoring, while key cellular processes are evolutionary conserved. Also with
respect to my PhD project concerning Ca2+ transport and permeability transition in
mitochondria, Drosophila seemed to be an interesting alternative to the mammalian
models, usually employed in these studies.
5.2 Drosophila cell lines
Despite the numerous advantages which Drosophila offers in various research fields,
using whole organisms as basic material for experiments has some limits. For example,
some mutations can have lethal effects in adults and therefore it becomes impossible
to compare mutant with wild type flies. Another disadvantage can be the heterogeneity
of the fully differentiated cell-types in the adult flies and thus an uneven response to
stimuli. Thus, for some research projects it becomes necessary to isolate specific
tissues, cells or organelles which, due to the size of the flies, can be a laborious and
time-consuming work which often results in an insufficient yield. This is especially the
case when mutations have an impact on growth and viability of the flies, and therefore
the number of adults is limited. Thus, in recent years cultured Drosophila cell lines
emerged as an important tool in different research fields. The cells are in most cases
derived from embryonic states, e.g. Schneider (S2) cells166, composed of a variety of
tissue precursors and are therefore undifferentiated. However, also tissue-specific
imaginal disc167 and CNS-derived168 cell lines have been established. All these cell lines
greatly facilitate biochemical studies and resolve the yield problem mentioned above,
43 INTRODUCTION
since they provide virtually unlimited amounts of homogenous material. With specific
respect to the aim of my PhD Thesis, they proved useful to obtain a sufficient amount
of mitochondria to perform studies on bioenergetics, Ca2+ fluxes and permeability
transition. Moreover, especially with new techniques like RNA-interference169, different
mutant cell lines can be generated, bypassing also the lethal effects of some mutations
on adult flies. Furthermore Drosophila cell lines have been successfully used in
heterologous protein expression studies and stable cell lines constitutively or
inductively expressing the desired protein could be created170-172. For the study of my
PhD Thesis I used the cell line S2R+(173) which is derived from late embryonic stages (20-
24h old embryos), and differs from its ancestor (S2) in that it has the ability to adhere to
tissue culture dishes. The primary culture was prepared and immortalized by I.
Schneider (1972) from enzymatically disaggregated embryos. For detailed information
on the exact procedure see166. Although Drosophila cell lines can be cultured in a similar
way as mammalian cell lines, some important differences should be considered174.
Drosophila cells should be grown at 25°C and need no CO2 buffering, the ideal gas being
ordinary air. Moreover, they do not show the phenomenon of “contact inhibition”,
displayed by mammalian cells. After forming a monolayer on the substrate, Drosophila
cells continue to proliferate, building more than one layer or growing in suspension.
5.3 Drosophila mitochondria in research
As soon as it became obvious that most of the genes implicated in human diseases have
at least one fly homolog175, Drosophila became a powerful tool to elucidate the
molecular and cellular mechanisms that underlie these disorders. Most research
projects concerning mitochondria from Drosophila are focused either on the
mitochondria-induced mechanisms of aging or on the mitochondrial involvement in
neurodegeneration with the aim to model human neurodegenerative disorders, such as
Alzheimer’s, Parkinson’s and Huntington’s disease.
Drosophila and aging
The mitochondrial electron transport chain is one of the primary sources of reactive
oxygen species (ROS) within cells, as ROS are by-products of respiration. While ROS
may have important roles in cell functions such as cell signaling, it has been discovered
44
that high levels of ROS also cause cellular damage176. Since the early fifties it was
hypothesized that the accumulation of molecular damage caused by ROS contributes
to the functional decline during the aging process177. A number of studies in Drosophila
confirmed an important role for mitochondrial ROS in modulating lifespan. Those
studies engineered flies with increased oxidative stress response by the adult-specific
overexpression of the mitochondrial Mn-Superoxide Dismutase (MnSOD), which led to
an increased lifespan178. Another approach to reduce oxidative stress was the reduction
of mitochondrial ROS production, which was achieved by the expression of the human
uncoupling protein 2 (hUCP2) in adult Drosophila neurons, again leading to the
extension of lifespan179. However, it cannot be excluded that the reduction of ROS
increases lifespan indirectly through changes in cell signaling or gene expression. Other
studies in Drosophila demonstrated age-related decreases in respiratory chain activity
and changes in mitochondrial structure180, 181. These observations can be explained
either by the damaging effect of ROS or by the decline in expression of genes that are
important for the electron transport chain with aging182.
Drosophila and neurodegeneration
Neurodegenerative diseases are a large group of disorders of the nervous system,
characterized by the progressive selective loss of neuronal subtypes such as
dopaminergic or motor neurons. Mitochondrial abnormalities have been documented in
neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s
diseases and amyotrophic lateral sclerosis and several studies have demonstrated that
mitochondrial impairment plays an important role in the pathogenesis of this group of
disorders (for an overview of the major findings in recent years see183, 184 and185). A
suitable model organism to study human neurodegenerative diseases should have
homologues to the genes mutated in the human disorder and should possess
neurobiological cellular processes (such as synapse formation and neuronal
communication) and neurobiological bases of behavior (such as sensory perception,
aspects of learning and memory formation) that are similar to those found in humans.
All of these criteria are fulfilled by Drosophila, where two approaches are commonly
used. First, the expression of a human disease gene in its wild type or mutant form in a
Drosophila tissue, usually the eye, and assessment of the corresponding phenotype186.
45 INTRODUCTION
Second, loss or gain of function analysis of the Drosophila homolog of the human
disease gene and assessment of the associated phenotypes165. A third possibility is the
screen of compounds in the already established Drosophila disease model in order to
pick out those that ameliorate the phenotype. This approach was successfully used in
fly models of adult-onset, age-related neurodegeneration and led to the complete
rescue of disease-related phenotypes187. Studies in the last two decades brought up
reliable Drosophila models for Alzheimer’s188, 189, Parkinson’s190, 191 and motor neuron
diseases192, as well as for trinucleotide expansion diseases193, such as ataxias194 and
Huntington’s disease195.
5.4 Involvement of Drosophila mitochondria in apoptosis
In mammalian cells the key step in mitochondrial-induced cell death occurs when the
OMM permeabilizes and several apoptogenic proteins, including cyt c, Smac/DIABLO,
AIF and endoG are released from the mitochondrial IMS29. In mammals, the subsequent
activation of caspases is dependent on cyt c-induced apoptosome formation196. The
process of MOMP is highly regulated by members of the Bcl-2 family. Like worms and
mammals, the Drosophila genome encodes at least two Bcl-2 family members197.
Sequence analysis revealed that Drosophila possesses seven members of the caspase
family198, which can be divided into initiator and effector caspases. The essential
apoptotic initiator caspase is named Dronc, and like mammalian caspase 2 and 9 it
interacts with Dark, the fly homolog of Apaf-1199. Consistently, Dronc can function as an
initiator caspase to cleave and activate the effector caspase Drice200.
However, conclusions about apoptotic pathways drawn on the basis of sequence
homologies should be taken with caution. Based on sequence, Drosophila might be
expected to require mitochondrial MOMP and cyt c release for caspase activation; yet,
unlike Apaf-1 in mammals, Dark does not appear to require cyt c to activate Dronc, and
several reports have found no indication that cyt c is released from Drosophila
mitochondria during apoptosis201-203. However, this is still a debated issue in the fly
community since two recent reports showed that cyt c translocates to the cytosol in
some types of cell death201, 204. To date, Drosophila cyt c has been linked to caspase
46
activation only during spermatid differentiation205 and to the proper timing of cell death
in the pupal eye206. Despite the debated role of cyt c it is well accepted that the key
players in regulation of the Drosophila apoptotic program are Diap1, a fly homolog of
the mammalian X-linked inhibitor of apoptosis proteins (XIAP) and its antagonists
Reaper, Hid, Grim and Sickle (RHG proteins). Diap1 is the key anti-apoptotic protein
in Drosophila and ensures cell survival by inhibiting caspase activity207. Apoptosis is
initiated by the binding of RHG proteins to Diap1, inducing its autoubiquitination and
proteasome-mediated degradation and resulting in the activation of effector
caspases208. Furthermore, it was recently found that Reaper and Hid proteins cause
mitochondrial fragmentation and release of cyt c in both cultured S2 cells and in the
developing fly embryo201.
Figure 11. Schematic representation of key proteins in mitochondrial-induced apoptotic pathways in vertebrates
and their Drosophila homologues. In healthy vertebrate cells, Apaf-1 is auto-inhibited and initiator caspase-9 as well as effector caspases -3 and -7 are inactive due to the binding to X-linked inhibitor of apoptosis protein (XIAP). An apoptotic stimulus leads to the activation of BH3-only proteins which bind to anti-apoptotic Bcl-2 proteins to remove their inhibitory effect or directly induce Bax/Bak channel formation which in turn triggers release of cytochrome c (cyt c), second mitochondria-derived activator of caspases (Smac)/direct inhibitor of apoptosis binding protein with low pI (Diablo), endonuclease G (endoG), apoptosis inducing factor (AIF), and Omi/HtrA2. Cyt c binds to Apaf-1 in the cytosol and thus induces apoptosome formation and activation of downstream caspases. Smac/DIABLO and Omi/HtrA2 bind to XIAP to remove its inhibitory effect. In Drosophila, the initiator caspase Dronc and the effector caspase Drice are ubiquitinated by Diap-1 for proteosomal degradation in healthy cells. Upon apoptotic signals, transcription of genes encoding for the pro-apoptotic proteins Reaper, Hid, Grim and sickle (RHG proteins) is induced, and RHG proteins translocate to mitochondria from where they recruit Diap-1 for interaction. The RHG proteins induce Diap-1 autoubiquitination and proteasomal degradation. Binding of Dark to mitochondria triggers apoptosome formation. dOmi might interact with the Drosophila homologue of the vertebrate XIAP, Diap-1 to remove the inhibitory effect of Diap-1 on caspases. Whether cyt c is released by Drosophila mitochondria during apoptosis is debated. Ortholog proteins in vertebrates and Drosophila are labeled in the same shape and color; modified from
209.
caspase activator
initiator caspase
effector caspase
cyt c
?Inhibitor of apoptosis protein
47 INTRODUCTION
Figure 12. Interaction of the key players in Drosophila cell death. In the absence of apoptotic signals, the initiator caspase Dronc and the effector caspase DrICE bind to the Drosophila inhibitor of apoptosis protein (Diap1), which ubiquitinates the caspases via its RING domain. Ubiquitylation inactivates the caspases without proteasomal degradation. The RING domain of Diap1 is also capable of ubiquitylating Reaper. In the presence of apoptotic stimuli, the RHG proteins displace the caspases from Diap1 and stimulate auto-ubiquitylation and proteasomal degradation of Diap1. Dronc is free to bind to the caspase activator Dark for apoptosome formation leading to activation of DrICE for cell death induction; modified from
208.
However, the possible lack of MOMP and cyt c release in Drosophila cell death does not
necessarily mean that mitochondria are not important during apoptosis in flies. Indeed,
there is strong evidence for mitochondria as a docking site to bring the key players in
apoptosis into close proximity. Reaper, Hid and Grim were all found to localize to
mitochondria. Hid possesses a hydrophobic C-terminal mitochondrial targeting
sequence210 and seems to recruit the other pro-apoptotic RHG proteins via their GH3
domain, an amphipathic helix conserved between Grim, Reaper and Sickle and essential
for their Diap1 degradation and killing activity211. It was hypothesized that Reaper may
be part of a high-order complex at the OMM to locally regulate Diap1 turnover and
caspase activity 212. The Bcl-2 homologues Debcl and Buffy do not seem to play a pivotal
role in developmental cell death in flies as analyzed in either single or double knockout
Dark
Dark
RHG
proteins
48
flies213. Surprisingly, the fly Bcl-2 homologues are able to induce cell death in
mammalian cells214. Taken together, these results suggest that Bcl-2 proteins in
Drosophila can potentially induce apoptosis, and that flies can bypass the need of Bcl-2
proteins by another regulatory strategy, i.e. transcriptional control of the potent Diap1
inhibitors Reaper, Hid, Grim and Sickle. Thus, Drosophila does not require the control of
Bcl-2 proteins to regulate MOMP and the release of IAP antagonist (such as Smac and
Omi), as is the case in mammals209.
It is not known whether additional cell death pathways that depend on mitochondrial
Ca2+ and oxidative stress are active in Drosophila. These pathways in mammals are
mediated by the PTP, but whether Ca2+ transport- and PTP-dependent IMM
permeabilization can also play a role in Drosophila was not known. This is the topic of
my PhD work.
49 MATERIALS AND METHODS
MATERIALS AND METHODS
50
51 MATERIALS AND METHODS
I. S2R+-cells
I.1 Cell culture
Cells were cultured in Schneider’s insect medium (Gibco) supplemented with 10% heat-
inactivated fetal bovine serum (culture medium). Culture medium for the transfected
S2R+pActCypD/pCoPuro cells was supplemented with 8 µg/µl puromycin. Depending on
the desired culture size cells were kept in 75cm2 T flasks or in tissue culture dishes
(245x245x25mm). S2R+ cells grow as adherent monolayers as well as in suspension.
Cells were incubated in a 25°C thermostated room and split every three or four days at
1:5 to 1:10 dilutions.
I.2 Cell permeabilization
Cells were detached with a sterile cell scraper, centrifuged at 200 x g for 10 min and
washed twice with Dulbecco’s phosphate buffered saline (PBS) without Ca2+ and Mg2+,
pH 7.4 (Euroclone). The resulting pellet was resuspended in 130 mM KCl, 10 mM MOPS-
Tris, pH 7.4 (KCl medium) containing 150 µM digitonin and 1 mM EGTA-Tris and
incubated for 20 min on ice (6 x 107 cells x ml-1). Cells were then diluted 1:5 in KCl
medium containing 10 µM EGTA-Tris and centrifuged at 200 x g in a refrigerated
centrifuge (4°C) for 6 min. The final pellet was resuspended in KCl medium containing
10 µM EGTA-Tris at 4 x 108 cells x ml-1 and kept on ice.
I.3 Subcellular fractionation
Cell membranes were lysed by hypotonic shock in a medium containing 10 mM Tris-
HCl, pH 6.7, 10 mM KCl, 150 µM MgCl2 supplemented with protease and phosphatase
inhibitor cocktails (Sigma) for 30 min on ice, followed by further disruption of the cell
membranes using a 26 G x ½" syringe (Artsana). Hypotonic shock was stopped by the
addition of sucrose at a final concentration of 250 mM and differential centrifugation
was performed for subcellular fractionation. Lysates were centrifuged three times at
2,200 x g for 10 min at 4°C to remove nuclei and cell debris. The supernatant was
centrifuged another three times at 8,200 x g for 10 min at 4°C to separate mitochondria
from the cytoplasm.
52
I.4 Stable Transfection
Two million cells were plated in each well of a 6-well tissue culture plate in 2 ml culture
medium per well. Cells were incubated for 5 h at room temperature (RT) for attachment
and then transfected with the Effectene® Transfection Reagent kit (Qiagen). Selection
vector (pCoPuro) and expression vector (pActCypD) were used in a 1:20 ratio. PCoPuro
(0.3 µg) and pActCypD (6 µg) were mixed with 50.4 µl Enhancer and 543.4 µl EC-Buffer
and incubated for 5 min at RT, followed by the addition of 60 µl Effectene. The mixture
was incubated for 15 min at RT and then added drop-wise to the cells. After 3d the
medium was removed and culture medium containing 8 µg/ml puromycin (selection
medium) was added. Cells were maintained in selection medium and split to culture
flasks when they reached confluence. The whole selection process took about three
weeks.
II. Mitochondrial bioenergetics
II.1 Measurement of mitochondrial respiration
Rates of mitochondrial respiration were measured using a Clark-type oxygen electrode
(Yellow Springs Instruments, OH, USA) equipped with magnetic stirring and
thermostatic control maintained at 25°C, and additions were made through a syringe
port in the frosted glass stopper sealing the chamber. Initial O2 concentration in the 2
ml chamber at 25°C is 520 natoms O2/ml at air saturation. Intact S2R+ cells were
incubated in Hank’s Balanced Salt Solution (HBSS) supplemented with 5 mM Pi-Tris, pH
7.4 while digitonin-permeabilized cells were incubated in 130 mM KCl, 10 mM MOPS-
Tris, 5 mM Pi-Tris, 10 µM EGTA, pH 7.4. In both cases 2 x 107 cells were incubated in 2 ml
of medium, followed by the addition of a respiratory substrate (10 mM glucose in the
case of intact cells and 5 mM succinate-Tris in the case of permeabilized cells). Further
additions were made as indicated in the figure legends. Addition of ADP allows
oxidative phosphorylation to proceed, dissipating some of the protonmotive force and
thereby stimulating electron transport (state 3 respiration). The rate of O2 consumption
after the addition of the FOF1 ATP synthase inhibitor oligomycin (state 4 respiration) is
an indicator of how coupled mitochondrial respiration is to ATP synthesis and the ratio
between state 3/state 4 is called respiratory control ratio. Addition of an uncoupler
53 MATERIALS AND METHODS
(protonophore) fully dissipates the protonmotive force and stimulates O2 consumption
maximally (uncoupled respiration). When the O2 concentration falls to zero, respiration
ceases. O2 consumption was calculated according to the slope of the registered graph,
and plotted as ng atoms O2 x min-1 x mg-1, or cells-1.
Figure 13. Schematic representation of a polarographic Clark type oxygen electrode trace. Shown are effects of respiratory substrates, ADP, oligomycin and uncouplers on the oxygen consumption rate in coupled mitochondria. State 3 = ADP-stimulated coupled respiration, state 4 = basal respiration in the absence of ADP or in the presence of oligomycin, that is a specific inhibitor of the FOF1 ATP synthase, uncoupled respiration = stimulated respiration due to a proton leak of the inner mitochondrial membrane induced e.g. by an uncoupler (protonophore).
II.2 Measurement of mitochondrial membrane potential
Mitochondrial membrane potential (ΔΨm) was measured using a Perkin-Elmer
spectrofluorometer and evaluated based on the uptake of the positively charged
fluorescent probe Rhodamine123, which accumulates in energized mitochondria
because of their inside negative ΔΨm. The intensity of the registered fluorescence
corresponds to the concentration of the probe in the medium, because under the
chosen experimental conditions intramitochondrial fluorescence of Rhodamine123 is
quenched. Thus, the higher ΔΨm, the lower the fluorescence of Rhodamine123. Two
cells substrate
ADP
oligomycin
uncoupler
oxyg
en c
once
ntra
tion
time
state 3
state 4
uncoupled
54
milliliters of assay medium (130 mM KCl, 10 mM MOPS-Tris, 5 mM Pi-Tris, 10 µM EGTA,
0.15 µM Rhodamine123, pH 7.4) were added to the cuvette. The fluorescence of
Rhodamine123 was monitored at the excitation and emission wavelengths of 503 and
523 nm, respectively, with the slit width set at 2.5 nm. After a short incubation to reach
stabilization of the signal, 2 x 107 permeabilized S2R+ cells were added to the cuvette.
Further additions were as indicated in the figure legends.
Figure 14. Evaluation of mitochondrial membrane potential (ΔΨm) based on Rhodamine123 fluorescence. Shown is a scheme illustrating a typical trace recorded at a fluorimeter.
III. Mitochondrial Ca2+ transport and permeability transition
III.1 Measurement of mitochondrial Ca2+ fluxes and Ca2+ retention capacity
The mitochondrial CRC-assay was used to assess opening of the Drosophila Ca2+-
induced Ca2+ release channel in permeabilized S2R+ cells. The Ca2+ threshold needed to
open the channel can be determined by adding Ca2+-pulses of known concentrations at
short intervals. Opening of the Ca2+-induced Ca2+ release channel is marked by a sudden
release of the accumulated Ca2+. Extramitochondrial Ca2+ was measured with Calcium
Green 5N (Molecular Probes) using either a Perkin-Elmer LS50B spectrofluorometer
Rh
od
amin
e 12
3fl
uo
resc
ence
cells
substrate
inhibitor/uncoupler
time
55 MATERIALS AND METHODS
equipped with magnetic stirring (excitation and emission wavelengths of 505 and 535
nm, respectively) or a Fluoroskan Ascent FL (Thermo Electron Corp.) equipped with a
plate shaker (excitation and emission wavelengths of 485 and 538 nm, respectively with
a 10-nm bandpass filter). The incubation medium contained 130 mM KCl or 250 mM
sucrose, 10 mM MOPS-Tris, 5 mM succinate-Tris, 10 µM EGTA, 2 µM rotenone, 0.5 µM
Calcium Green 5N, pH 7.4 and Pi-Tris as indicated in the figure legends. Permeabilized
cells (2 x 107 in a final volume of 2 ml in the Perkin-Elmer spectrofluorometer and 2 x 106
in a final volume of 0.2 ml in the Fluoroskan) were used. Further additions were made as
indicated in the figure legends.
Calcium Green 5N is a Ca2+-sensitive dye, not permeable to the mitochondrial inner
membrane. Therefore, adding a Ca2+-pulse to the cell suspension leads to a peak in
Calcium Green 5N fluorescence, followed by an immediate decrease of the latter when
Ca2+ is taken up by mitochondria. When a threshold-concentration of matrix Ca2+ is
reached, the Ca2+-induced Ca2+ release channel opens, which leads to a release of Ca2+
out of the mitochondria and thus to a quick increase in Calcium Green 5N fluorescence.
Figure 15. Calcium Retention Capacity (CRC) assay. Extramitochondrial Ca2+
is measured fluorimetrically by the Ca2+
-sensitive dye Calcium Green 5N. Addition of a Ca
2+ pulse to the mitochondria or permeabilized cells leads to increase
in fluorescence (1) followed by an immediate decrease of the latter when Ca2+
is taken up by mitochondria (2). When a threshold concentration of Ca
2+ accumulated in the matrix is reached, the Ca
2+-induced Ca
2+ release channel opens
leading to a quick increase in fluorescence (3).
10 min
10 µM Ca2+ each
Ca
2+
-gre
en 5
N fl
uo
resc
ence
incr
ease
1
2
3
56
III.2 Light scattering
The light scattering technique is based on the correlation between mitochondrial
matrix volume and the optical density of the mitochondrial suspension. Intact
mitochondria scatter light at 540-nm wavelength. An increase in matrix volume due to
mitochondrial swelling leads to a decrease in light scattering. Light scattering at 90°
was monitored with a Perkin-Elmer LS50B spectrofluorimeter at 540 nm with a 5.5 nm
slit width. Twenty million permeabilized cells in a final volume of 2 ml were incubated in
a medium containing 130 mM KCl, 10 mM MOPS-Tris, 5 mM succinate-Tris, 10 µM
EGTA, 2 µM rotenone, pH 7.4 and Pi-Tris as indicated in the figure legends.
Figure 16. Schematic representation of the light scattering technique as indicator of mitochondrial volume changes.
Addition of alamethicin (a pore-forming peptide) or valinomycin (a K+-ionophore) to a mitochondrial or permeabilized
cell suspension leads to a decrease in light scattering indicating mitochondrial swelling (b), (a) = control trace without any additions.
IV. Epifluorescence microscopy
IV.1 Fluorescent staining of S2R+ cell mitochondria
Energization of mitochondria in both intact and permeabilized S2R+ cells was analyzed
based on accumulation of the potentiometric probe tetramethyl rhodamine methyl
ester (TMRM, Molecular Probes), that accumulates in mitochondria based on their
inside-negative ΔΨm. Three days before the experiments cells were seeded onto
Ligh
t sca
tter
ing
dec
reas
e
a
alamethicin/valinomycin
b
time
57 MATERIALS AND METHODS
sterilized 24-mm round glass coverslips at 2 x 106 cells per well in 2 ml culture medium.
On the day of experiment cells were washed once with PBS and incubated for 20 min at
RT with 1 ml of serum-free Schneider’s medium supplemented with 1 µg/ml Cyclosporin
H (CsH) and 10 nM TMRM. CsH is an inhibitor of the plasma membrane multidrug
resistance pumps that does not affect the PTP of mammals and allows an appropriate
loading with the probe by preventing its extrusion at the plasma membrane215, 216.
Images were acquired with an Olympus IX71/IX51 inverted microscope equipped with a
xenon light source (75 W) for epifluorescence illumination, and with a 12-bit digital
cooled CCD camera (Micromax). For detection of TMRM fluorescence, 568 ± 25-nm
bandpass excitation and 585-nm longpass emission filter settings were used.
IV.2 Immunofluorescence
One day before the experiments stably transfected S2R+pActCypD cells were seeded on
sterilized 13-mm round glass coverslips in a 24-well tissue culture plate at 2 x 105 cells
per well in 0.5 ml of culture medium. On the day of experiment cells were washed once
with PBS and incubated for 20 min at RT with 0.5 ml of serum-free Schneider’s medium
supplemented with 1 µg/ml CsH and 100 nM Mitotracker® Red CMXRos (Molecular
Probes) for mitochondrial staining. After another washing step with PBS, cells were
fixed with 4% paraformaldehyde for 20 min at RT. Cells were washed again with PBS,
permeabilized with 50 mM NH4Cl in PBS + 0.1% Triton for 5 min at RT, washed again
and blocked with PBS containing 3% goat serum for 1h at RT. Monoclonal anti-HA
(clone HA-7, Sigma) diluted 1:100 in PBS with 2% goat serum was added to the cells and
incubated over night at 4°C. On the next day cells were washed 3 times with PBS and
the immunoreaction was revealed with FITC-conjugated anti-mouse IgG (Fab-specific,
Sigma) at a working dilution of 1:500 in PBS with 2% goat serum for 45 min at RT. After
another three washings in PBS coverslips were mounted with Mowiol and examined
with an Olympus epifluorescence microscope at 60x magnification.
58
V. Electron microscopy
S2R+ cells were washed with PBS and fixed in 2.5% glutaraldehyde in 0.1 M K+
phosphate buffer pH 7.4 for 2 h at 4°C. After washing with 0.15 M K+ phosphate buffer
pH 7.0 cells were finally embedded in 2% gelatin as previously described217. Gelatin-
embedded samples were post-fixed with 1% osmium tetroxide in cacodylate buffer 0.1
M, pH 7.4, and embedded in Epon812 resin, sectioned and stained following standard
procedures218. Ultrathin sections were observed with a Philips EM400 transmission
electron microscope operating at 100 Kv.
VI. SDS-PAGE and Western Blotting
VI.1 Sample preparation
Cells were pelleted at 3,000 x g and mitochondria at 8,200 x g at 4°C and resuspended in
a lysis buffer (LB) containing 150 mM NaCl, 20 mM Tris, pH 7.4, 5 mM EDTA-Tris, 10%
Glycerol, 1% Triton X-100, supplemented with protease and phosphatase inhibitor
cocktails (Sigma), and kept on ice for 20 min. Lysates were then centrifuged at 18,000 x
g for 25 min at 4°C to remove insoluble materials. The supernatants were solubilized in
Laemmli gel sample buffer containing 10% sodium dodecyl sulfate (SDS), 250 mM Tris,
pH 6.8, 50% glycerol, 12.5% ß-mercaptoethanol and 0.02% bromophenol blue.
Cytoplasmic fractions and post-cellular supernatants were concentrated by adding five
volumes -20°C acetone to one volume of sample. Samples were kept overnight at -20°
and finally centrifuged at 18,000 x g for 30 min at 4°C. The pellets were resuspended in
20% methanol, centrifuged again at 18,000 x g for 15 min at 4°C and finally solubilized
in Laemmli gel sample buffer.
VI.2 SDS-PAGE
All samples to be run on the SDS-PAGE were previously solubilized in Laemmli gel
sample buffer and denatured by boiling for 5 min. Samples were then loaded and
separated electrophoretically in a 15% polyacrylamide gel.
59 MATERIALS AND METHODS
VI.3 Western Blotting
Separated proteins were transferred electrophoretically to nitrocellulose membranes in
a buffer containing 0.5 M glycine, 0.4 M Tris and 20% methanol at 4°C using a Mini
Trans-Blot system (Bio-Rad). The membrane was then saturated for 1 h in PBS
containing 3% nonfat dry milk and 0.02% Tween to avoid non-specific protein binding.
Saturated membranes were incubated with a primary antibody overnight at 4°C. The
next day membranes were washed three times in PBS/ 0.02% Tween for 5 min each and
incubated with a secondary horseradish peroxidase-conjugated antibody (anti-mouse,
anti-rabbit or anti-goat, depending on the source of the primary antibody) in PBS
containing 3% nonfat dry milk and 0.02% Tween for 1 h and 30 min at RT. After another
three washings, the antibody protein binding was revealed by the ECL (Enhanced
ChemiLuminescence; Milipore) kit.
antibody source company dilution
anti-cytochrome c mouse
monoclonal
BD Pharmingen 1:500
anti-OxPhos complex IV
subunit I
mouse
monoclonal
Invitrogen 1:500
anti-TOM20 rabbit
polyclonal
Santa Cruz
Biotechnology
1:300-
1:500
anti-HA mouse
monoclonal
Sigma 1:1000
anti-Cyp-D mouse
monoclonal
Calbiochem 1:1000-
1:3000
anti-actin goat
polyclonal
Santa Cruz
Biotechnology
1:1000
anti-caspase3 rabbit
polyclonal
Cell Signalling 1:1000
Table 1. List of all primary antibodies for Western Blotting used in this work.
60
VII. Plasmids and constructs
VII.1 Cloning of human Cyp-D cDNA into a Drosophila expression vector
Total RNA was extracted from the human osteosarcoma cell line HQB17 with TRIzol®
Reagent (Invitrogen) according to the manufacturer’s protocol. cDNA was synthesized
using SuperScriptTM II Reverse Transcriptase (Invitrogen), following the manufacturer’s
instructions. A construct of human Cyp-D cDNA carrying a mitochondrial targeting
sequence (MTS) from Drosophila Hsp60 (a mitochondrial matrix protein) at its 5’ end
and an HA-tag at its 3’ end was created by polymerase chain reaction (PCR) using a
forward primer carrying the MTS and a reverse primer carrying the HA-tag. Exchange of
the human MTS for a Drosophila MTS was meant to assure proper localization of the
heterologous protein in the mitochondrial matrix upon translation in the Drosophila cell
line, and the attachment of the nonapeptide HA (YPYDVPDYA) at the C-terminus was
aimed to facilitate the detection of the heterologous protein by Western Blot or
Immunofluorescence analysis. Long primers K_MTSCYPD_FWD and S_HACYPD_REV
were used for generation of the MTS_CypD_HA construct from human cDNA by PCR.
The second shorter primer pair (K_MTS_FWD and S_HA_REV) was used for screening
of proper insertion in the vector by colony PCR, as described below.
name sequence
K_MTSCYPD_FWD ctGGTACCATGTTCCGTTTGCCAGTTTCGCTTGCTCGCTCCTCCA
TTAGCCGCCAGTTGGCCATGCGCGGCTATGCCAAGGATGTGTG
CAGCAAGGGCTCCGGCGACCCG
S_HACYPD_REV ccGAGCTCTTAAGCGTAATCTGGAACATCGTATGGGTAGCTCAA
CTGGCCACAGTCTGTGATG
K_MTS_FWD ctGGTACCATGTTCCGTTTGCCAGTTTCGCTTG
S_HA_REV ccGAGCTCTTAAGCGTAATCTGGAACATCGTATG Table 2. Primers used for generation of a cDNA MTS-CypD-HA construct. Forward (FWD) and reverse (REV) primer contain cleavage sites for the restriction enzymes KpnI GGTACC and SacI GAGCTC (in red).
PCRs were performed in a 50 μl reaction mixture containing:
- 100 ng cDNA
- 25 µl 2x Phusion® High-Fidelity Master Mix with HF Buffer (Finnzymes)
- 10 µM primer K_MTSCYPD_FWD
- 10 µM primer S_HACYPD_REV
61 MATERIALS AND METHODS
cycle step temperature time cycles
denaturation 98°C 5 min 1
denaturation
annealing
extension
98°C
60°C
72°C
30 sec
30 sec
1 min
30
final extension 72°C 10 min 1 Table 3. PCR amplification protocol for generation of a cDNA MTS-CypD-HA construct.
A further incubation step at 72°C for 10 min was performed with GoTaq® DNA
polymerase (Promega) to add an adenine (A)-overhang at the 3’ end of the PCR
product.
Figure 17. cDNA sequence of the MTS-CypD-HA construct. The mitochondrial targeting sequence (MTS) of the human Cyp-D sequence was exchanged for an MTS of Drosophila Hsp60 (a mitochondrial matrix protein; cyan) in order to assure proper mitochondrial localization of the heterologous protein in Drosophila. The sequence encoding for an HA-tag (pink) was attached to the 3’ end of the human Cyp-D cDNA sequence (yellow) in order to facilitate detection of the protein. Restriction enzyme sites attached to the 3’ and 5’ ends are not shown.
The obtained 654 bp PCR product was ligated into the pGEM®-T vector (Promega)
according to the manufacturer’s instructions and the resulting vector was used to
transform One Shot TOP10 E. coli cells (Invitrogen).
MTS Hsp60 DrosophilaHA Taghuman Cyp-D cDNA
ATGTTCCGTTTGCCAGTTTCGCTTGCTCGCTCCTCCATTAGCCGCCAGTTGGCCATGCGCGGCTATGCCAAGGATGTGTGCAGCAAGGGCTCCGGCGACCCGTCCTCTTCCTCCTCCTCCGGGAACCCGCTCGTGTACCTGGACGTGGACGCCAACGGGAAGCCGCTCGGCCGCGTGGTGCTGGAGCTGAAGGCAGATGTCGTCCCAAAGACAGCTGAGAACTTCAGAGCCCTGTGCACTGGTGAGAAGGGCTTCGGCTACAAAGGCTCCACCTTCCACAGGGTGATCCCTTCCTTCATGTGCCAGGCGGGCGACTTCACCAACCACAATGGCACAGGCGGGAAGTCCATCTACGGAAGCCGCTTTCCTGACGAGAACTTTACACTGAAGCACGTGGGGCCAGGTGTCCTGTCCATGGCTAATGCTGGTCCTAACACCAACGGCTCCCAGTTCTTCATCTGCACCATAAAGACAGACTGGTTGGATGGCAAGCATGTTGTGTTCGGTCACGTCAAAGAGGGCATGGACGTCGTGAAGAAAATAGAATCTTTCGGCTCTAAGAGTGGGAGGACATCCAAGAAGATTGTCATCACAGACTGTGGCCAGTTGAGCTACCCATACGATGTTCCAGATTACGCTTAA
62
Figure 18. pGEM®-T vector map and sequence reference points.
Positive clones were detected by β-galactosidase screening and colony PCR.
Furthermore, all the constructs were fully sequenced to assess the in-frame insertion of
the cDNA and to control for unwanted mutations (BMR Genomics).
The 50 µl reaction mixture for colony PCR contained:
- 3 µl bacterial suspension grown overnight from a single colony
- 5 µl 10x PCR buffer
- 10 µM primer K_MTS_FWD
- 10 µM primer S_HA_REV
- 25 mM MgCl2
- 10 mM dNTPs (10 mM each dATP, dTTP, dGTP, dCTP)
- 2.5 u GoTaq® DNA polymerase (Promega)
cycle step temperature time cycles
denaturation 95°C 10 min 1
denaturation
annealing
extension
95°C
58°C
72°C
45 sec
45 sec
1 min
30
final extension 72°C 10 min 1 Table 4. Colony PCR amplification protocol for detection of MTS-CypD-HA-positive clones.
63 MATERIALS AND METHODS
Using conventional restriction enzyme digestion techniques, the MTS_CypD_HA
sequence was extracted with SacI from the pGEM®-T vector (SacI cuts at the 3’ end of
the MTS_CypD_HA insert as well as upstream the 5’ end in the multiple cloning site of
the pGEM®-T vector) and ligated into the pAct Drosophila transformation vector, which
was linearized with the same restriction enzyme. The resulting pActCypD vector
contains the MTS_CypD_HA construct under the control of the Drosophila actin 5C
promoter, which drives constitutive expression of the heterologous protein. Positive
clones were detected with colony PCR, as described above. The vector was purified by
Miniprep and sequenced again in order to screen for plasmids containing the
MTS_CypD_HA construct inserted in the right direction.
Figure 19. pAct vector map.
The expression vector pActCypD was co-transfected with the selection vector pCoPuro
(Addgene plasmid 17533, coding for puromycin-resistance) into Drosophila S2R+ cells, in
order to generate a stable polyclonal cell population, constitutively expressing human
Cyp-D. Transfection procedure and selection process were performed as described
above.
64
Figure 20. pCoPuro vector map and sequence reference points.
Feature Name Start End
pGEX_3_primer 51 29
lacZ_a 393 250
M13_pUC_fwd_primer 364 386
M13_forward20_primer 379 395
puro (variant) 894 1493
pBluescriptKS_primer 1643 1627
SV40_PA_terminator 1661 1792
EBV_rev_primer 1749 1768
M13_pUC_rev_primer 1855 1833
lac_promoter 1898 1869
pBR322_origin 2826 2207
Ampicillin 3841 2981
AmpR_promoter 3911 3883
pCoPuro4041 bp
65 RESULTS
RESULTS
66
67 RESULTS
Part I: Properties of a Selective Ca2+-induced Ca2+ Release
Channel in Mitochondria of Drosophila melanogaster
Mitochondria are key players in cellular Ca2+ homeostasis and are thereby involved in a
wide field of physiological processes such as buffering of cytoplasmic Ca2+ signals,
excitation-contraction coupling and induction of cell death. Indeed, the mitochondrial
proton electrochemical gradient Δμ�H is used not only to synthesize ATP but also to
accumulate cations into the mitochondrial matrix. Ca2+ uptake into respiring
mitochondria is mediated by the mitochondrial Ca2+ uniporter (MCU), localized in the
inner mitochondrial membrane (IMM), while exchangers (Ca2+ for Na+ and ⁄ or H+) are
responsible for Ca2+ efflux. However, mitochondria are exposed to the danger of Ca2+
overload when matrix Ca2+ load exceeds the capacity of IMM exchangers and thus, an
additional Ca2+ efflux pathway may exist in mitochondria through opening of the
permeability transition pore (PTP). The mitochondrial permeability transition (PT)
describes a process of Ca2+-dependent, tightly regulated increase in the permeability of
the IMM due to the opening of a high-conductance channel, the PTP. Prolonged
opening of the PTP causes mitochondrial depolarization, loss of ionic homeostasis,
depletion of pyridine nucleotides, respiratory inhibition, matrix swelling, release of
cytochrome c and cell death via apoptosis or necrosis depending on a variety of
additional factors, among which cellular ATP and Ca2+ levels play a major role. On the
other hand, transient openings of the PTP (flickering) may be involved in physiological
Ca2+ homeostasis. The PTP has been thoroughly characterized based on its sensitivity
to a large number of effectors, but its molecular nature remains elusive.
In spite of its importance as a model organism, remarkably little was known about the
properties of Ca2+ transport in mitochondria of the fruit fly Drosophila melanogaster,
and on whether these mitochondria can undergo a PT. Thus, we studied the pathways
for Ca2+ transport in mitochondria in the embryonic Drosophila cell line S2R+ and
identified a selective mitochondrial Ca2+-dependent Ca2+ release channel displaying
features intermediate between the mammalian PTP and the pore of yeast. The results
of this study are illustrated in Publication 1 and the conclusions are summarized in the
final Section of this Thesis.
68
Publication 1
69 RESULTS
70
71 RESULTS
72
73 RESULTS
74
75 RESULTS
76
Supplemental Material for
Properties of Ca2+ Transport in Mitochondria of
Drosophila melanogaster
Sophia von Stockum, Emy Basso, Valeria Petronilli, Patrizia Sabatelli, Michael A. Forte,
Paolo Bernardi
Supplementary Figure 1. Oxygen consumption rates in intact and permeabilized Drosophila S2R
+ cells. A,
cells were incubated in Hank’s balanced salt solution supplemented with 10 mM glucose and 5 mM Pi-Tris,
pH 7.4 and respiration recorded with a Clark-type oxygen electrode under basal conditions, after the
addition of 1 μg/ml oligomycin followed by that of 50 nM FCCP. B, digitonin-permeabilized cells were
incubated in 130 mM KCl, 10 mM MOPS-Tris, 5 mM succinate-Tris, 5 mM Pi-Tris and 10 μM EGTA-Tris, pH
7.4 and basal respiration measured, followed by the addition of 0.1 mM ADP, 1 μg/ml oligomycin and 50
nM FCCP. Respiratory rates are average ± SD from three independent experiments.
ng a
tom
sO
2, x
min
-1, x
107
cells
-1
0
4
8
12A B
77 RESULTS
Supplementary Figure 2. Effect of CsA, Ub0, ADP and oligomycin on CRC of permeabilized Drosophila
S2R+ cells. Experimental conditions were as in Fig. 2 except that the concentration of Pi was 5 mM (A) or 1
mM (B). The CRC was determined in protocols identical to those shown in Fig. 4 in the absence of further
additions (ctrl), or in the presence of 2 μg/ml CsA, 5 μM Ub0 or 0.1 mM ADP plus 1μg/ml oligomycin
(Oligo). CRC values are normalized to those observed in absence of additions other than Ca2+ (CRC0).
Experiments were performed in triplicate and reported values are average ± SD.
Supplementary Figure 3. Effect of valinomycin and alamethicin on light scattering in permeabilized
Drosophila S2R+ cells. Experimental conditions were as in Fig. 2, and 90° light scattering changes were
measured at 540 nm. Where indicated 150 nM (trace b) or 1 μM (trace c) valinomycin (Val) and 3 μM
alamethicin (Ala) were added. Trace a, no valinomycin. The figure shows representative traces from three
independent experiments.
0
0.5
1.0
1.5C
RC
/CR
C0
Pi 5mMA
Pi 1mMB
Val Ala
light
sca
tterin
gd
ecre
ase
a
b
c
78
Part II: Expression of Human Cyclophilin D in Drosophila
melanogaster Cells – Impact on Regulation of the Drosophila
Mitochondrial Ca2+ Release Channel
A key modulator of the mammalian permeability transition pore (PTP) is Cyclophilin D
(Cyp-D), a mitochondrial peptidyl-prolyl-cis-trans isomerase (PPIase) that in mice is
encoded by the Ppif gene and that plays an important role in protein folding. Cyp-D can
be selectively inhibited by the immunosuppressant drug Cyclosporin A (CsA) and
genetic Cyp-D ablation (or treatment with CsA) remarkably desensitizes the PTP in
that its opening requires about twice the Ca2+ load necessary to open the PTP in ctrl
mitochondria. Recently, it was shown that the desensitizing effect of Cyp-D ablation or
CsA treatment on the pore is only seen in the presence of Pi, but not when the latter is
replaced by its analogues arsenate or vanadate. These results suggest that when Cyp-D
does not bind to the PTP (because of genetic ablation or of the binding to CsA) Pi can
bind to an inhibitory site on the pore thereby delaying pore opening68.
The Drosophila genome encodes for fourteen different Cyclophilins. However,
according to sequence analysis219 and GFP-tagging (unpublished results) there is no
Drosophila Cyclophilin with a predicted mitochondrial localization. As described in Part
I, the Drosophila Ca2+-induced Ca2+ release channel has some similar characteristics to
the mammalian PTP, but possesses also some unique features in that it is insensitive to
CsA, selective to Ca2+ and H+ and inhibited by Pi. Another striking difference between
the pore of Drosophila and that of mammals is the lack of mitochondrial swelling and
cytochrome c release during the opening of the channel. Taken together, these results
suggest that the PTP is a phenomenon conserved throughout evolution, although it is
regulated in different manners in different species. In this second part of the study, we
investigated if the lack of sensitivity of the Drosophila channel to CsA is due to a lacking
mitochondrial Cyclophilin and what the evolutionary role of Cyp-D is in pore regulation.
Thus, we stably expressed a human Cyp-D construct in the Drosophila embryonic cell
line S2R+ in order to investigate the impact of the heterologous protein on regulation of
the Drosophila Ca2+-induced Ca2+ release channel.
79 RESULTS
In order to express the human Cyp-D protein in S2R+ cells, we cloned a construct of
human Cyp-D cDNA carrying a Drosophila MTS at its 5’ end and an HA-tag at its 3’ end
in the Drosophila expression vector pAct, that drives constitutive expression of the
heterologous protein.
Exchange of the human MTS for a Drosophila MTS was meant to assure proper
localization of Cyp-D in the mitochondrial matrix upon translation in the Drosophila cell
line, and the attachment of an HA-tag at the C-terminus was aimed at facilitating the
detection of the heterologous protein by Western Blot or Immunofluorescence analysis.
Cells were transfected with the expression vector pActCypD and the selection vector
pCoPuro (encoding for puromycin-resistance) in a 20:1 ratio in order to minimize the
occurrence of cells containing the selection but not the expression vector. A careful
titration of puromycin was performed in order to define the proper concentration able
to kill non-transfected ctrl cells but not puromycin-resistant pActCypD/pCoPuro cells.
Puromycin-resistant cells were selected over three weeks to obtain a stable polyclonal
cell population.
First, we wanted to analyze if and to what extend the transfected cells express human
Cyp-D. Therefore we performed Western Blot analysis of total cell lysates and
subcellular fractions, showing that S2R+ pActCypD-HA cells express the heterologous
Cyp-D in a comparable amount to a human osteosarcoma cell line (SAOS) expressing
the endogenous form (Figure 21 A) and that heterologous Cyp-D is mostly localized in
the mitochondria (Figure 21 B). The faint band of Cyp-D in the cytoplasmic fraction
could be due to the very high expression of the heterologous protein under the control
of the actin 5C promoter. Mitochondrial localization of human Cyp-D in S2R+ cells was
confirmed by Immunofluorescence analysis (Figure 21 C).
80
Figure 21. Expression level and subcellular localization of human Cyclophilin D expressed in Drosophila S2R+ cells. (A)
Western Blot analysis of total cell lysates from non-transfected S2R+ cells (S2R
+ ctrl), S2R
+ cells stably transfected with
pAct-CypD and pCoPuro vectors (S2R+pActCyp-D-HA) and human osteosarcoma cells (SAOS). Immunoblotting was
performed with antibodies against Cyp-D, HA-tag and actin as internal loading control. The slight difference in molecular weight between the heterologously and the endogenously expressed Cyp-D is due to the HA-tag. (B) Western Blot analysis of cytosolic and mitochondrial fractions from S2R
+pActCyp-D-HA showing the subcellular
localization of Cyp-D. Antibodies against caspase-3 (Casp-3) and translocase of outer membrane 20 (TOM20) were used as markers for cytosol and mitochondria, respectively and were meant to address the purity of subcellular fractions. (C) Subcellular localization of Cyp-D in S2R
+pActCyp-D-HA addressed by Immunofluorescence. Mitochondria
were stained with Mitotracker Red CMXRos (red fluorescence) and cells were incubated with a specific antibody against the HA-tag attached to Cyp-D, followed by incubation with FITC-conjugated anti-mouse IgG (green fluorescence). The right panel shows the merged image from red and green fluorescence.
HA
actin
Cyp-D
Cyp-D
Casp-3
TOM20
A B
MitoTracker anti-HA tag merge
C
81 RESULTS
In order to address the impact of human Cyp-D on the Drosophila Ca2+-induced Ca2+ release
channel we studied the CRC in cells co-transfected with the expression vector pActCypD and the
selection vector pCoPuro compared to ctrl cells transfected exclusively with the pCoPuro vector.
Cyp-D expression strikingly reduced the CRC in pActCypD/pCoPuro cells compared to ctrl cells
irrespective of the Pi concentration (Figure 22 A, panels a and a’). CsA was not able to prevent
the inducing effect of Cyp-D on the Drosophila Ca2+-induced Ca2+ release channel (Figure 22 A,
panels b and b’) and was ineffective in ctrl cells, as shown in Part I. We believe that Cyp-D acts
specifically on the Ca2+ release channel since the potent PTP inhibitor rotenone73 restored the
CRC in Cyp-D-expressing cells, which became able to accumulate Ca2+ in a comparable amount to
ctrl cells (Figure 22 A, panels c and c’). Figure 22 A shows an extreme case in which Cyp-D
expression led to immediate opening of the Drosophila Ca2+-induced Ca2+ release channel and
prevented any Ca2+ uptake by mitochondria. Figure 22 B shows ratios of CRCs in the absence or
presence of Cyp-D (in the latter case of course only experiments where some Ca2+ uptake took
place were considered). The lack of sensitivity to CsA might be due to a very high affinity of the
human Cyp-D for the Drosophila pore and/or to the high abundance of the overexpressed Cyp-D,
which may require higher CsA concentrations for displacement from the Ca2+ release channel, an
issue that will be addressed in the future.
82
Figure 22. Effect of human Cyp-D on mitochondrial Ca2+
retention capacity (CRC) in permeabilized Drosophila S2R+
cells. (A) Digitonin-permeabilized S2R+ cells transfected either with pActCypD expression vector and pCoPuro selection
vector (Cyp-D, panels a’-c’) or only with the selection vector (ctrl, panels a-c) were incubated in 250 mM sucrose, 10 mM MOPS-Tris, 5 mM succinate-Tris, 10 µM EGTA, 0.5 µM Calcium Green 5N, pH 7.4 and Pi-Tris, as shown in the figure. In panels b and b’ the medium was supplemented with 0.8 µM CsA and in panels c and c’ with 2 µM rotenone. Extramitochondrial Ca
2+ was monitored, and CRC was determined by stepwise addition of 5 µM Ca
2+ pulses. (B) The
amount of Ca2+
accumulated prior to onset of Ca2+
-induced Ca2+
release without further additions, in the presence of 2 µM rotenone (+ rotenone) or 0.8 µM CsA (+ CsA) was normalized to that obtained in the ctrl cells. Note that only the values where some Ca
2+ uptake could be observed were included in this graph. Error bars report the standard
deviation of three different experiments.
Ca
2+gr
ee
n f
luo
resc
en
ce0.5 mM Pi 5 mM Pi
Cyp-Dctrl
0.5 mM Pi 5 mM Pi
+ ro
ten
on
e+
CsA
6 min
a a’
b b’
5 µM Ca2+ each 5 µM Ca2+ each 5 µM Ca2+ each 5 µM Ca2+ each
c c’
A
0
0.2
0.4
0.6
0.8
1
1.2
0.5 mM Pi
ctrl
Cyp-D
CR
C/C
RC
ctrl
5 mM Pi
+ CsA + CsA+ rotenone + rotenone
B
83 CONCLUSIONS
CONCLUSIONS
84
85 CONCLUSIONS
In this study we characterized Ca2+ transport mechanisms in one of the most popular
and widely used model organism, Drosophila melanogaster. In particular we identified a
novel mitochondrial Ca2+-dependent Ca2+ release channel in a digitonin-permeabilized
embryonic Drosophila cell model, displaying features intermediate between the
mammalian PTP and the pore of yeast. Like the mammalian PTP, Drosophila Ca2+
release is inhibited by tetracaine and opens in response to matrix Ca2+ loading, inner
membrane depolarization, thiol oxidation, and treatment with relatively high
concentrations of NEM. Like the yeast pore (and at variance from the mammalian PTP),
the Drosophila channel is inhibited by Pi and insensitive to CsA. A striking difference
between the pore of Drosophila and that of mammals is its selectivity to Ca2+ and H+ and
the lack of mitochondrial swelling and cyt c release during the opening of the channel.
Available evidence points to persistent activation of the PTP as a prime mediator of
apoptotic and necrotic cell death in mammals. As described in Chapter 5.4,
permeabilization of mitochondrial membranes might not be required to induce the
Drosophila apoptotic pathways and cyt c seems to be dispensable for activation of
down-stream caspases. However, it is unknown if Ca2+-mediated cell death pathways
do exist in Drosophila cells. Our results indicate that the Drosophila Ca2+-induced Ca2+
release channel might be more involved into Ca2+ homeostasis than into cell death
induction due to the fact that its opening does not cause morphological changes and
membrane permeabilization in mitochondria. However, this issue can now be
addressed based on the results of the second part of this study, in which we were able
to express human Cyp-D in Drosophila S2R+ cells. The heterologous protein was properly
targeted to the mitochondria and decreased the Ca2+ retention capacity of Cyp-D-
expressing cells in a rotenone-sensitive but CsA-insensitive manner. If the Cyp-D in
Drosophila cells changes selectivity, size and properties of the Ca2+-induced Ca2+ release
channel can now be addressed. It will be particularly interesting to investigate if Cyp-D
induces the swelling of mitochondria undergoing Ca2+ release, and if mitochondria do
now release cyt c. This could shed further light on the evolution of the PTP and
mitochondria-mediated cell death pathways in the animal kingdom. Furthermore, we
can benefit from the sophisticated genetic strategies that Drosophila provides to define
the molecular nature of the PTP and its role in pathophysiology of Ca2+ homeostasis.
86
87 REFERENCES
REFERENCES
88
89 REFERENCES
1. Tovar, J. et al. Mitochondrial remnant organelles of Giardia function in iron-sulphur protein maturation. Nature 426, 172-176 (2003).
2. Williams, B. A. P., Hirt, R. P., Lucocq, J. M. & Embley, T. M. A mitochondrial remnant in the microsporidian Trachipleistophora hominis. Nature 418, 865-869 (2002).
3. McBride, H. M., Neuspiel, M. & Wasiak, S. Mitochondria: more than just a powerhouse. Current Biology 16, R551-R560 (2006).
4. Youle, R. J. & Van Der Bliek, A. M. Mitochondrial fission, fusion, and stress. Science
337, 1062-1065 (2012).
5. Liu, X. & Hajnóczky, G. Ca2+-dependent regulation of mitochondrial dynamics by the Miro-Milton complex. International Journal of Biochemistry and Cell Biology 41, 1972-1976 (2009).
6. http://www.origin-of-mitochondria.net.
7. http://molpath.ucsd.edu/.
8. Nass, M. M. & Nass, S. Intramitochondrial fibers with DNA characteristics. I. Fixation and electron staining reactions. J. Cell Biol. 19, 593-611 (1963).
9. http://www.wadsworth.org/rvbc/cryo.html.
10. Mitchell, P. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol.Rev.Camb.Philos.Soc. 41, 445-502 (1966).
11. Abrahams, J. P., Leslie, A. G. W., Lutter, R. & Walker, J. E. Structure at 2.8 A resolution of F1-ATPase from bovine heart mitochondria. Nature 370, 621-628 (1994).
12. Wittig, I. & Schägger, H. Structural organization of mitochondrial ATP synthase. Biochim. Biophys. Acta 1777, 592 (2008).
13. Collinson, I. R., Skehel, J. M., Fearnley, I. M., Runswick, M. J. & Walker, J. E. The F1FO-ATPase complex from bovine heart mitochondria: the molar ratio of the subunits in the stalk region linking the F1 and FO domains. Biochemistry 35, 12640-12646 (1996).
14. Noji, H., Yasuda, R., Yoshida, M. & Kinosita, K. Direct observation of the rotation of F1-ATPase. Nature 386, 299-302 (1997).
15. Walker, J. E. & Dickson, V. K. The peripheral stalk of the mitochondrial ATP synthase. Biochim. Biophys. Acta 1757, 286 (2006).
16. Cabezon, E., Montgomery, M. G., Leslie, A. G. W. & Walker, J. E. The structure of bovine F1-ATPase in complex with its regulatory protein IF1. Nat. Struct. Biol. 10, 744-750 (2003).
90
17. Green, D. W. & Grover, G. J. The IF(1) inhibitor protein of the mitochondrial F(1)F(0)-ATPase. Biochim. Biophys. Acta 1458, 343-355 (2000).
18. Symersky, J., Osowski, D., Walters, D. E. & Mueller, D. M. Oligomycin frames a common drug-binding site in the ATP synthase. Proceedings of the National Academy of
Sciences 109, 13961-13965 (2012).
19. Granata, S. et al. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics 10 (2009).
20. Kerr, J. F., Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972).
21. Wu, W., Liu, P. & Li, J. Necroptosis: An emerging form of programmed cell death. Crit. Rev. Oncol. 82, 249-258 (2012).
22. Li, J. & Yuan, J. Caspases in apoptosis and beyond. Oncogene 27, 6194-6206 (2008).
23. Fischer, U., Jänicke, R. & Schulze-Osthoff, K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death & Differentiation 10, 76-100 (2003).
24. Li, H., Zhu, H., Xu, C. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-502 (1998).
25. Katz, C. et al. Molecular basis of the interaction between proapoptotic truncated BID (tBID) protein and mitochondrial carrier homologue 2 (MTCH2) protein: key players in mitochondrial death pathway. J. Biol. Chem. 287, 15016-15023 (2012).
26. Riedl, S. J. & Salvesen, G. S. The apoptosome: signalling platform of cell death. Nature Reviews Molecular Cell Biology 8, 405-413 (2007).
27. Joza, N. et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410, 549-554 (2001).
28. Hotchkiss, R. S., Strasser, A., McDunn, J. E. & Swanson, P. E. Cell death. N. Engl. J.
Med. 361, 1570-1583 (2009).
29. Danial, N. N. & Korsmeyer, S. J. Cell death: critical control points. Cell 116, 205-219 (2004).
30. Soriano, M. E. & Scorrano, L. Traveling Bax and forth from mitochondria to control apoptosis. Cell 145, 15-17 (2011).
31. Wei, M. C. et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14, 2060-2071 (2000).
32. Martinou, J. C. & Youle, R. J. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Developmental cell 21, 92-101 (2011).
91 REFERENCES
33. Rizzuto, R., Duchen, M. R. & Pozzan, T. Flirting in little space: the ER/mitochondria Ca2+ liaison. Science Signalling 2004, re1 (2004).
34. DeLuca, H. & Engstrom, G. Calcium uptake by rat kidney mitochondria. Proc. Natl.
Acad. Sci. U. S. A. 47, 1744 (1961).
35. Rizzuto, R. et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science 280, 1763-1766 (1998).
36. Rizzuto, R., Bernardi, P. & Pozzan, T. Mitochondria as all-round players of the calcium game. J. Physiol. (Lond. ) 529, 37-47 (2004).
37. Kirichok, Y., Krapivinsky, G. & Clapham, D. E. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 427, 360-364 (2004).
38. De Stefani, D., Raffaello, A., Teardo, E., Szabò, I. & Rizzuto, R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476, 336-340 (2011).
39. Baughman, J. M. et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476, 341-345 (2011).
40. Nicholls, D. G. Mitochondrial calcium function and dysfunction in the central nervous system. Biochimica et Biophysica Acta (BBA)-Bioenergetics 1787, 1416-1424 (2009).
41. Azzone, G., Pozzan, T., Massari, S., Bragadin, M. & Dell'Antone, P. H /site ratio and steady state distribution of divalent cations in mitochondria. FEBS Lett. 78, 21 (1977).
42. Nicholls, D. G. The regulation of extramitochondrial free calcium ion concentration by rat liver mitochondria. Biochem. J. 176, 463 (1978).
43. Bernardi, P. & Pietrobon, D. On the nature of Pi-induced, Mg2+-prevented Ca2+ release in rat liver mitochondria. FEBS Lett. 139, 9-12 (1982).
44. Mitchell, P. Keilin's respiratory chain concept and its chemiosmotic consequences. Science 206, 1148-1159 (1979).
45. Kristian, T., Pivovarova, N. B., Fiskum, G. & Andrews, S. B. Calcium-induced precipitate formation in brain mitochondria: composition, calcium capacity, and retention. J. Neurochem. 102, 1346-1356 (2007).
46. Palty, R. et al. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc. Natl. Acad. Sci. U. S. A. 107, 436-441 (2010).
47. Pfeiffer, D. R., Gunter, T. E., Eliseev, R., Broekemeier, K. M. & Gunter, K. K. Release of Ca2+ from mitochondria via the saturable mechanisms and the permeability transition. IUBMB Life 52, 205-212 (2008).
92
48. Drago, I., Pizzo, P. & Pozzan, T. After half a century mitochondrial calcium in-and efflux machineries reveal themselves. EMBO J. 30, 4119-4125 (2011).
49. Bragadin, M., Pozzan, T. & Azzone, G. F. Kinetics of calcium (2+) ion carrier in rat liver mitochondria. Biochemistry (N. Y. ) 18, 5972-5978 (1979).
50. Bernardi, P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 79, 1127-1155 (1999).
51. Bernardi, P. & Petronilli, V. The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J. Bioenerg. Biomembr. 28, 131-138 (1996).
52. Rasola, A., Sciacovelli, M., Pantic, B. & Bernardi, P. Signal transduction to the permeability transition pore. FEBS Lett. 584, 1989-1996 (2010).
53. Bernardi, P. et al. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS Journal 273, 2077-2099 (2006).
54. Kung, G., Konstantinidis, K. & Kitsis, R. N. Programmed necrosis, not apoptosis, in the heart. Circ. Res. 108, 1017-1036 (2011).
55. Nicolli, A., Petronilli, V. & Bernardi, P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by matrix pH. Evidence that the pore open-closed probability is regulated by reversible histidine protonation. Biochemistry (N. Y. )
32, 4461-4465 (1993).
56. Bernardi, P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J. Biol. Chem. 267, 8834-8839 (1992).
57. Lê Quôc, K. & Lê Quôc, D. Involvement of the ADP/ATP carrier in calcium-induced perturbations of the mitochondrial inner membrane permeability: importance of the orientation of the nucleotide binding site. Arch. Biochem. Biophys. 265, 249 (1988).
58. Hunter, D. R. & Haworth, R. A. The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch. Biochem. Biophys. 195, 453-459 (1979).
59. Halestrap, A. & Davidson, A. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem. J. 268, 153-160 (1990).
60. Fontaine, E., Eriksson, O., Ichas, F. & Bernardi, P. Regulation of the permeability transition pore in skeletal muscle mitochondria. J. Biol. Chem. 273, 12662-12668 (1998).
93 REFERENCES
61. Walter, L. et al. Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site. J. Biol. Chem. 275, 29521-29527 (2000).
62. Costantini, P., Chernyak, B. V., Petronilli, V. & Bernardi, P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271, 6746-6751 (1996).
63. Chernyak, B. V. & Bernardi, P. The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. European Journal of Biochemistry 238, 623-630 (2004).
64. Kowaltowski, A. J., Vercesi, A. E. & Castilho, R. F. Mitochondrial membrane protein thiol reactivity with N-ethylmaleimide or mersalyl is modified by Ca2+: correlation with mitochondrial permeability transition. Biochim. Biophys. Acta 1318, 395-402 (1997).
65. Petronilli, V. et al. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem. 269, 16638-16642 (1994).
66. Costantini, P., Chernyak, B. V., Petronilli, V. & Bernardi, P. Selective inhibition of the mitochondrial permeability transition pore at the oxidation-reduction sensitive dithiol by monobromobimane. FEBS Lett. 362, 239 (1995).
67. Seidlmayer, L. K., Gomez-Garcia, M. R., Blatter, L. A., Pavlov, E. & Dedkova, E. N. Inorganic polyphosphate is a potent activator of the mitochondrial permeability transition pore in cardiac myocytes. J. Gen. Physiol. 139, 321-331 (2012).
68. Basso, E., Petronilli, V., Forte, M. A. & Bernardi, P. Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation. J. Biol. Chem. 283, 26307-26311 (2008).
69. Giorgio, V. et al. Cyclophilin D in mitochondrial pathophysiology. Biochimica et
Biophysica Acta (BBA)-Bioenergetics 1797, 1113-1118 (2010).
70. Broekemeier, K., Dempsey, M. & Pfeiffer, D. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264, 7826-7830 (1989).
71. Scorrano, L., Nicolli, A., Basso, E. & Petronilli, V. P. Two modes of activation of the permeability transition pore: the role of mitochondrial cyclophilin. Mol. Cell. Biochem.
174, 181-184 (1997).
72. Nicolli, A., Basso, E., Petronilli, V., Wenger, R. M. & Bernardi, P. Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. J. Biol. Chem. 271, 2185-2192 (1996).
94
73. Li, B. et al. Inhibition of complex I regulates the mitochondrial permeability transition through a phosphate-sensitive inhibitory site masked by cyclophilin D. Biochimica et
Biophysica Acta (BBA)-Bioenergetics (2012).
74. Rasola, A. & Bernardi, P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12, 815-833 (2007).
75. Szabó, I. & Zoratti, M. The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore. FEBS Lett. 330, 201 (1993).
76. Szabó, I., De Pinto, V. & Zoratti, M. The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel. FEBS Lett. 330, 206 (1993).
77. Gincel, D., Zaid, H. & Shoshan-Barmatz, V. Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function. Biochem. J. 358, 147 (2001).
78. Zizi, M., Forte, M., Blachly-Dyson, E. & Colombini, M. NADH regulates the gating of VDAC, the mitochondrial outer membrane channel. J. Biol. Chem. 269, 1614-1616 (1994).
79. Gincel, D. & Shoshan-Barmatz, V. Glutamate interacts with VDAC and modulates opening of the mitochondrial permeability transition pore. J. Bioenerg. Biomembr. 36, 179-186 (2004).
80. Pastorino, J. G. & Hoek, J. B. Hexokinase II: the integration of energy metabolism and control of apoptosis. Curr. Med. Chem. 10, 1535-1551 (2003).
81. Xu, X., Decker, W., Sampson, M., Craigen, W. & Colombini, M. Mouse VDAC isoforms expressed in yeast: channel properties and their roles in mitochondrial outer membrane permeability. J. Membr. Biol. 170, 89-102 (1999).
82. Krauskopf, A., Eriksson, O., Craigen, W. J., Forte, M. A. & Bernardi, P. Properties of the permeability transition in VDAC1(-/-) mitochondria. Biochim. Biophys. Acta 1757, 590-595 (2006).
83. Baines, C. P., Kaiser, R. A., Sheiko, T., Craigen, W. J. & Molkentin, J. D. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat.
Cell Biol. 9, 550-555 (2007).
84. Haworth, R. A. & Hunter, D. R. M. Control of the mitochondrial permeability transition pore by high-affinity ADP binding at the ADP/ATP translocase in permeabilized mitochondria. J. Bioenerg. Biomembr. 32, 91-96 (2000).
85. Kokoszka, J. E. et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427, 461-465 (2004).
95 REFERENCES
86. Fontaine, E., Ichas, F. & Bernardi, P. A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J. Biol. Chem. 273, 25734-25740 (1998).
87. Cesura, A. M. et al. The voltage-dependent anion channel is the target for a new class of inhibitors of the mitochondrial permeability transition pore. J. Biol. Chem. 278, 49812-49818 (2003).
88. Leung, A. W. C., Varanyuwatana, P. & Halestrap, A. P. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J. Biol. Chem. 283, 26312-26323 (2008).
89. Varanyuwatana, P. & Halestrap, A. P. The roles of phosphate and the phosphate carrier in the mitochondrial permeability transition pore. Mitochondrion 12, 120-125 (2012).
90. Connern, C. P. & Halestrap, A. P. Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem. J. 302, 321 (1994).
91. Baines, C. P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662 (2005).
92. Reutenauer, J., Dorchies, O., Patthey-Vuadens, O., Vuagniaux, G. & Ruegg, U. Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Br. J. Pharmacol. 155, 574-584 (2009).
93. Sharpe, J. C., Arnoult, D. & Youle, R. J. Control of mitochondrial permeability by Bcl-2 family members. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1644, 107-113 (2004).
94. O'Gorman, E. et al. The role of creatine kinase in inhibition of mitochondrial permeability transition. FEBS Lett. 414, 253 (1997).
95. Mathupala, S., Ko, Y. & Pedersen, P. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25, 4777-4786 (2006).
96. Robey, R. & Hay, N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25, 4683-4696 (2006).
97. Šileikytė, J. et al. Regulation of the inner membrane mitochondrial permeability transition by the outer membrane translocator protein (peripheral benzodiazepine receptor). J. Biol. Chem. 286, 1046-1053 (2011).
98. Altschuld, R. A. et al. Cyclosporin inhibits mitochondrial calcium efflux in isolated adult rat ventricular cardiomyocytes. American Journal of Physiology - Heart and
Circulatory Physiology 262, H1699-H1704 (1992).
96
99. Eriksson, O., Pollesello, P. & Geimonen, E. Regulation of total mitochondrial Ca 2+ in perfused liver is independent of the permeability transition pore. American Journal of
Physiology - Cell Physiology 276, C1297-C1302 (1999).
100. Elrod, J. W. et al. Cyclophilin D controls mitochondrial pore - dependent Ca2+ exchange, metabolic flexibility, and propensity for heart failure in mice. J. Clin. Invest.
120, 3680-3687 (2010).
101. Barsukova, A. et al. Activation of the mitochondrial permeability transition pore modulates Ca 2+ responses to physiological stimuli in adult neurons. Eur. J. Neurosci. 33, 831-842 (2011).
102. Schinzel, A. C. et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl.
Acad. Sci. U. S. A. 102, 12005-12010 (2005).
103. Du, H. et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat. Med.
14, 1097-1105 (2008).
104. Wang, X. et al. Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. The Journal of Neuroscience 29, 2588-2596 (2009).
105. Guérin, B., Bunoust, O., Rouqueys, V. & Rigoulet, M. ATP-induced unspecific channel in yeast mitochondria. J. Biol. Chem. 269, 25406-25410 (1994).
106. Jung, D. W., Bradshaw, P. C. & Pfeiffer, D. R. Properties of a cyclosporin-insensitive permeability transition pore in yeast mitochondria. J. Biol. Chem. 272, 21104 (1997).
107. Manon, S., Roucou, X., Guerin, M., Rigoulet, M. & Guérin, B. Minireview: Characterization of the yeast mitochondria unselective channel: a counterpart to the mammalian permeability transition pore? J. Bioenerg. Biomembr. 30, 419-429 (1998).
108. Pérez-Vázquez, V., Saavedra-Molina, A. & Uribe, S. In Saccharomyces cerevisiae, cations control the fate of the energy derived from oxidative metabolism through the opening and closing of the yeast mitochondrial unselective channel. J. Bioenerg.
Biomembr. 35, 231-241 (2003).
109. Yamada, A. et al. Ca2+-induced permeability transition can be observed even in yeast mitochondria under optimized experimental conditions. Biochim. Biophys. Acta
1787, 1486-1491 (2009).
110. Fortes, F., Castilho, R. F., Catisti, R., Carnieri, E. G. S. & Vercesi, A. E. Ca2+ induces a cyclosporin A-insensitive permeability transition pore in isolated potato tuber mitochondria mediated by reactive oxygen species. J. Bioenerg. Biomembr. 33, 43-51 (2001).
97 REFERENCES
111. Arpagaus, S., Rawyler, A. & Braendle, R. Occurrence and characteristics of the mitochondrial permeability transition in plants. J. Biol. Chem. 277, 1780-1787 (2002).
112. Curtis, M. J. & Wolpert, T. J. The oat mitochondrial permeability transition and its implication in victorin binding and induced cell death. The Plant Journal 29, 295-312 (2003).
113. Virolainen, E., Blokhina, O. & Fagerstedt, K. Ca2+ -induced high amplitude swelling and cytochrome c release from wheat (Triticum aestivum l.) mitochondria under anoxic stress. Annals of Botany 90, 509-516 (2002).
114. Lin, J., Wang, Y. & Wang, G. Salt stress-induced programmed cell death in tobacco protoplasts is mediated by reactive oxygen species and mitochondrial permeability transition pore status. J. Plant Physiol. 163, 731-739 (2006).
115. Toninello, A., Salvi, M. & Colombo, L. The membrane permeability transition in liver mitochondria of the great green goby Zosterisessor ophiocephalus (Pallas). J. Exp. Biol.
203, 3425-3434 (2000).
116. Azzolin, L., Basso, E., Argenton, F. & Bernardi, P. Mitochondrial Ca2+ transport and permeability transition in zebrafish (Danio rerio). Biochim. Biophys. Acta 1797, 1775-1779 (2010).
117. Hanada, H. et al. Cyclosporin A inhibits thyroid hormone-induced shortening of the tadpole tail through membrane permeability transition. Comparative Biochemistry and
Physiology Part B: Biochemistry and Molecular Biology 135, 473-483 (2003).
118. Savina, M. V., Emelyanova, L. V. & Belyaeva, E. A. Bioenergetic parameters of lamprey and frog liver mitochondria during metabolic depression and activity. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology
145, 296-305 (2006).
119. Azzolin, L. et al. The mitochondrial permeability transition from yeast to mammals. FEBS Lett. 584, 2504-2509 (2010).
120. Nichols, B., Rigoulet, M. & Denton, R. Comparison of the effects of Ca2+ , adenine nucleotides and pH on the kinetic properties of mitochondrial NAD (+ )-isocitrate dehydrogenase and oxoglutarate dehydrogenase from the yeast Saccharomyces cerevisiae and rat heart. Biochem. J. 303, 461 (1994).
121. Manon, S. & Guérin, M. Evidence for three different electrophoretic pathways in yeast mitochondria: ion specificity and inhibitor sensitivity. J. Bioenerg. Biomembr. 25, 671-678 (1993).
122. Bazhenova, E. N., Deryabina, Y. I., Eriksson, O., Zvyagilskaya, R. A. & Saris, N. E. L. Characterization of a high capacity calcium transport system in mitochondria of the yeast Endomyces magnusii. J. Biol. Chem. 273, 4372-4377 (1998).
98
123. Bradshaw, P. C., Jung, D. W. & Pfeiffer, D. R. Free fatty acids activate a vigorous Ca2+:2H+ antiport activity in yeast mitochondria. J. Biol. Chem. 276, 40502-40509 (2001).
124. Ballarin, C. & Sorgato, M. C. An electrophysiological study of yeast mitochondria. J. Biol. Chem. 270, 19262-19268 (1995).
125. Matouschek, A., Rospert, S., Schmid, K., Glick, B. S. & Schatz, G. Cyclophilin catalyzes protein folding in yeast mitochondria. Proc. Natl. Acad. Sci. U. S. A. 92, 6319-6323 (1995).
126. Kowaltowski, A. J., Vercesi, A. E., Rhee, S. G. & Netto, L. E. Catalases and thioredoxin peroxidase protect Saccharomyces cerevisiae against Ca(2+)-induced mitochondrial membrane permeabilization and cell death. FEBS Lett. 473, 177-182 (2000).
127. Marks, A. R. Cellular functions of immunophilins. Physiol. Rev. 76, 631-649 (1996).
128. Handschumacher, R. E., Harding, M. W., Rice, J., Drugge, R. J. & Speicher, D. W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science (New York, NY)
226, 544 (1984).
129. Liu, J. et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815 (1991).
130. Kang, B. H. et al. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 131, 257-270 (2007).
131. Giorgio, V. et al. Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J. Biol. Chem. 284, 33982-33988 (2009).
132. Eliseev, R. A. et al. Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J. Biol. Chem. 284, 9692-9699 (2009).
133. Argaud, L. et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J. Mol. Cell. Cardiol. 38, 367-374 (2005).
134. Clarke, S. J., McStay, G. P. & Halestrap, A. P. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. J. Biol. Chem. 277, 34793-34799 (2002).
135. Gomez, L. et al. Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. American Journal of Physiology-Heart and Circulatory Physiology 293, H1654-H1661 (2007).
136. Azzolin, L. et al. Antamanide, a derivative of amanita phalloides, is a novel inhibitor of the mitochondrial permeability transition pore. PloS one 6, e16280 (2011).
99 REFERENCES
137. Basso, E. et al. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J. Biol. Chem. 280, 18558-18561 (2005).
138. Nakagawa, T. et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652-658 (2005).
139. Li, Y., Johnson, N., Capano, M., Edwards, M. & Crompton, M. Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis. Biochem. J. 383, 101 (2004).
140. Matas, J. et al. Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy. J. Mol. Cell.
Cardiol. 46, 420-430 (2009).
141. Wolpert, L. et al. Principles of development. 1998. Current Biology Ltd London.
142. Adoutte, A. et al. The new animal phylogeny: reliability and implications. Proc. Natl.
Acad. Sci. U. S. A. 97, 4453-4456 (2000).
143. Peterson, K. J. et al. Estimating metazoan divergence times with a molecular clock. Proc. Natl. Acad. Sci. U. S. A. 101, 6536-6541 (2004).
144. Rubin, G. M. et al. Comparative genomics of the eukaryotes. Science 287, 2204-2215 (2000).
145. Wunderlich, Z. & DePace, A. H. Modeling transcriptional networks in Drosophila development at multiple scales. Curr. Opin. Genet. Dev. 21, 711-718 (2011).
146. Helfand, S. L. & Rogina, B. Genetics of aging in the fruit fly, Drosophila melanogaster. Annu. Rev. Genet. 37, 329-348 (2003).
147. Song, Y. H. Drosophila melanogaster: a model for the study of DNA damage checkpoint response. Mol. Cells 19, 167-179 (2005).
148. Wilhelm, J. E. & Smibert, C. A. Mechanisms of translational regulation in Drosophila. Biology of the Cell 97, 235-252 (2005).
149. Davies, S. A. Signalling via cGMP: lessons from Drosophila. Cell. Signal. 18, 409-421 (2006).
150. Davis, R. L. Olfactory memory formation in Drosophila: from molecular to systems neuroscience. Annu. Rev. Neurosci. 28, 275-302 (2005).
151. Hirth, F. Drosophila melanogaster in the study of human neurodegeneration. CNS &
neurological disorders drug targets 9, 504 (2010).
100
152. Hardin, P. E. The circadian timekeeping system of Drosophila. Curr. Biol. 15, R714-22 (2005).
153. Adams, M. D. et al. The genome sequence of Drosophila melanogaster. Science 287, 2185-2195 (2000).
154. www.flybase.net.
155. St Johnston, D. The art and design of genetic screens: Drosophila melanogaster. Nature Reviews Genetics 3, 176-188 (2002).
156. Pandey, U. B. & Nichols, C. D. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol. Rev. 63, 411-436 (2011).
157. Bilen, J. & Bonini, N. M. Drosophila as a model for human neurodegenerative disease. Annu. Rev. Genet. 39, 153-171 (2005).
158. Woodhouse, E. C. & Liotta, L. A. Drosophila invasive tumors: a model for understanding metastasis. Cell Cycle 3, 37-39 (2004).
159. Wolf, M. J. et al. Drosophila as a model for the identification of genes causing adult human heart disease. Proc. Natl. Acad. Sci. U. S. A. 103, 1394-1399 (2006).
160. Saitoe, M., Horiuchi, J., Tamura, T. & Ito, N. Drosophila as a novel animal model for studying the genetics of age-related memory impairment. Rev. Neurosci. 16, 137-150 (2005).
161. Celotto, A. M., Chiu, W. K., Van Voorhies, W. & Palladino, M. J. Modes of metabolic compensation during mitochondrial disease using the Drosophila model of ATP6 dysfunction. PloS one 6, e25823 (2011).
162. Fernández-Ayala, D. J. M., Chen, S., Kemppainen, E., MC O'Dell, K. & Jacobs, H. T. Gene expression in a Drosophila model of mitochondrial disease. PloS one 5, e8549 (2010).
163. Zordan, M. A. et al. Post-transcriptional silencing and functional characterization of the Drosophila melanogaster homolog of human Surf1. Genetics 172, 229-241 (2006).
164. Rubin, G. M. & Spradling, A. C. Genetic transformation of Drosophila with transposable element vectors. Science 218, 348-353 (1982).
165. Venken, K. J. T. & Bellen, H. J. Emerging technologies for gene manipulation in Drosophila melanogaster. Nature Reviews Genetics 6, 167-178 (2005).
166. Schneider, I. Cell lines derived from late embryonic stages of Drosophila melanogaster. J. Embryol. Exp. Morphol. 27, 353-365 (1972).
101 REFERENCES
167. Ui, K., Ueda, R. & Miyake, T. Cell lines from imaginal discs of Drosophila melanogaster. In Vitro Cellular & Developmental Biology-Plant 23, 707-711 (1987).
168. Ui, K. et al. Newly established cell lines from Drosophila larval CNS express neural specific characteristics. In Vitro Cellular & Developmental Biology-Animal 30, 209-216 (1994).
169. Clemens, J. C. et al. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proceedings of the National Academy of
Sciences 97, 6499-6503 (2000).
170. Moraes, A. M. et al. Drosophila melanogaster S2 cells for expression of heterologous genes: From gene cloning to bioprocess development. Biotechnol. Adv. 30, 613-628 (2012).
171. González, M. et al. Generation of stable Drosophila cell lines using multicistronic vectors. Scientific reports 1 (2011).
172. Iwaki, T., Figuera, M., Ploplis, V. A. & Castellino, F. J. Rapid selection of Drosophila S2 cells with the puromycin resistance gene. BioTechniques 35, 482-4, 486 (2003).
173. Yanagawa, S., Lee, J. S. & Ishimoto, A. Identification and characterization of a novel line of Drosophila Schneider S2 cells that respond to wingless signaling. J. Biol. Chem.
273, 32353-32359 (1998).
174. Cherbas, L. & Cherbas, P. Drosophila cell culture and transformation. Cold Spring
Harbor Protocols 2007, pdb. top6 (2007).
175. Reiter, L. T., Potocki, L., Chien, S., Gribskov, M. & Bier, E. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 11, 1114-1125 (2001).
176. Beckman, K. B. & Ames, B. N. The free radical theory of aging matures. Physiol. Rev.
78, 547-581 (1998).
177. Harman, D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11, 298-300 (1956).
178. Sun, J., Folk, D., Bradley, T. J. & Tower, J. Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. Genetics 161, 661-672 (2002).
179. Fridell, Y. W. C., Sánchez-Blanco, A., Silvia, B. A. & Helfand, S. L. Targeted expression of the human uncoupling protein 2 (hUCP2) to adult neurons extends life span in the fly. Cell metabolism 1, 145-152 (2005).
102
180. Walker, D. W. & Benzer, S. Mitochondrial “swirls” induced by oxygen stress and in the Drosophila mutant hyperswirl. Proc. Natl. Acad. Sci. U. S. A. 101, 10290-10295 (2004).
181. Oda, Y., Yui, R., Sakamoto, K., Kita, K. & Matsuura, E. T. Age-related changes in the activities of respiratory chain complexes and mitochondrial morphology in Drosophila. Mitochondrion 12, 345-351 (2012).
182. McCarroll, S. A. et al. Comparing genomic expression patterns across species identifies shared transcriptional profile in aging. Nat. Genet. 36, 197-204 (2004).
183. Johri, A. & Beal, M. F. Mitochondrial dysfunction in neurodegenerative diseases. J. Pharmacol. Exp. Ther. 342, 619-630 (2012).
184. Filosto, M. et al. The role of mitochondria in neurodegenerative diseases. J. Neurol.
258, 1763-1774 (2011).
185. Kwong, J. Q., Beal, M. F. & Manfredi, G. The role of mitochondria in inherited neurodegenerative diseases. J. Neurochem. 97, 1659-1675 (2006).
186. Bonini, N. M. & Fortini, M. E. Human neurodegenerative disease modeling using Drosophila. Annu. Rev. Neurosci. 26, 627-656 (2003).
187. Chang, S. et al. Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nature chemical biology 4, 256-263 (2008).
188. Moloney, A., Sattelle, D. B., Lomas, D. A. & Crowther, D. C. Alzheimer's disease: insights from Drosophila melanogaster models. Trends Biochem. Sci. 35, 228-235 (2010).
189. Iijima-Ando, K. & Iijima, K. Transgenic Drosophila models of Alzheimer’s disease and tauopathies. Brain Structure and Function 214, 245-262 (2010).
190. Muñoz-Soriano, V. & Paricio, N. Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies. Parkinson's Disease
2011 (2011).
191. Park, J., Kim, Y. & Chung, J. Mitochondrial dysfunction and Parkinson’s disease genes: insights from Drosophila. Disease Models & Mechanisms 2, 336-340 (2009).
192. Watson, M. R., Lagow, R. D., Xu, K., Zhang, B. & Bonini, N. M. A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J. Biol.
Chem. 283, 24972-24981 (2008).
193. Yu, Z. & Bonini, N. M. Modeling human trinucleotide repeat diseases in Drosophila. Recent advances in the use of drosophila in neurobiology and neurodegeneration 99, 191 (2011).
194. Puccio, H. Multicellular models of Friedreich ataxia. J. Neurol. 256, 18-24 (2009).
103 REFERENCES
195. Green, E. W. & Giorgini, F. Choosing and using Drosophila models to characterize modifiers of Huntington's disease. Biochem. Soc. Trans. 40, 739 (2012).
196. Kulikov, A. et al. Cytochrome c: the Achilles’ heel in apoptosis. Cellular and
Molecular Life Sciences, 1-11 (2012).
197. Chen, P. & Abrams, J. M. Drosophila apoptosis and Bcl-2 genes: Outliers fly in. J. Cell
Biol. 148, 625-628 (2000).
198. Kumar, S. Caspase function in programmed cell death. Cell Death & Differentiation
14, 32-43 (2006).
199. Oberst, A., Bender, C. & Green, D. R. Living with death: the evolution of the mitochondrial pathway of apoptosis in animals. Cell Death & Differentiation 15, 1139-1146 (2008).
200. Hawkins, C. J. et al. The Drosophila caspase DRONC cleaves following glutamate or aspartate and is regulated by DIAP1, HID, and GRIM. J. Biol. Chem. 275, 27084-27093 (2000).
201. Abdelwahid, E. et al. Mitochondrial disruption in Drosophila apoptosis. Dev. Cell.
12, 793-806 (2007).
202. Dorstyn, L., Mills, K., Lazebnik, Y. & Kumar, S. The two cytochrome c species, DC3 and DC4, are not required for caspase activation and apoptosis in Drosophila cells. J. Cell
Biol. 167, 405-410 (2004).
203. Means, J. C., Muro, I. & Clem, R. J. Lack of involvement of mitochondrial factors in caspase activation in a Drosophila cell-free system. Cell Death & Differentiation 13, 1222-1234 (2005).
204. Goyal, G., Fell, B., Sarin, A., Youle, R. J. & Sriram, V. Role of mitochondrial remodeling in programmed cell death in Drosophila melanogaster. Dev. Cell. 12, 807-816 (2007).
205. Arama, E., Agapite, J. & Steller, H. Caspase activity and a specific cytochrome c are required for sperm differentiation in Drosophila. Dev. Cell. 4, 687-697 (2003).
206. Mendes, C. S. et al. Cytochrome c-d regulates developmental apoptosis in the Drosophila retina. EMBO Rep. 7, 933-939 (2006).
207. O'Riordan, M. X. D., Bauler, L. D., Scott, F. L. & Duckett, C. S. Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation. Developmental cell 15, 497-508 (2008).
208. Xu, D. et al. Genetic control of programmed cell death (apoptosis) in Drosophila. Fly
3, 78-90 (2009).
104
209. Wang, C. & Youle, R. J. The role of mitochondria in apoptosis. Annual Review of
Genetics 43, 95-118 (2009).
210. Haining, W., Carboy-Newcomb, C., Wei, C. & Steller, H. The proapoptotic function of Drosophila Hid is conserved in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 96, 4936-4941 (1999).
211. Clavería, C., Caminero, E., Martínez-A, C., Campuzano, S. & Torres, M. GH3, a novel proapoptotic domain in Drosophila Grim, promotes a mitochondrial death pathway. EMBO J. 21, 3327-3336 (2002).
212. Sandu, C., Ryoo, H. D. & Steller, H. Drosophila IAP antagonists form multimeric complexes to promote cell death. J. Cell Biol. 190, 1039-1052 (2010).
213. Sevrioukov, E. A. et al. Drosophila Bcl-2 proteins participate in stress-induced apoptosis, but are not required for normal development. Genesis 45, 184-193 (2007).
214. Zhang, H. et al. Drosophila pro-apoptotic Bcl-2/Bax homologue reveals evolutionary conservation of cell death mechanisms. J. Biol. Chem. 275, 27303-27306 (2000).
215. Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V. & Di Lisa, F. Mitochondria and cell death. European Journal of Biochemistry 264, 687-701 (2001).
216. Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V. & Di Lisa, F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur. J. Biochem. 264, 687-701 (1999).
217. Taupin, P. Processing scarce biological samples for light and transmission electron microscopy. Eur. J. Histochem. 52, 135-139 (2008).
218. Angelin, A. et al. Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc. Natl.
Acad. Sci. U. S. A. 104, 991-996 (2007).
219. Pemberton, T. J. & Kay, J. E. Identification and comparative analysis of the peptidyl-prolyl cis/trans isomerase repertoires of H. sapiens, D. melanogaster, C. elegans, S. cerevisiae and Sz. pombe. Comp. Funct. Genomics 6, 277-300 (2005).
105 APPENDIX
APPENDIX
106
107 APPENDIX
A. Publication 2
108
109 APPENDIX
110
111 APPENDIX
112
113 APPENDIX
B. Publication 3
114
115 APPENDIX
116
117 APPENDIX
118